{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:02:18Z","timestamp":1794646938423,"version":"4.9.1"},"reference-count":439,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Natural Science Foundation of Shanxi Province","award":["202503021211266"],"award-info":[{"award-number":["202503021211266"]}]},{"DOI":"10.13039\/501100002858","name":"china postdoctoral foundation committee","doi-asserted-by":"crossref","award":["2021M691995"],"award-info":[{"award-number":["2021M691995"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Viral infections are a major contributor to global cancer incidence and mortality. However, integrative reviews that connect viral classification, carcinogenic mechanisms, tumor microenvironment remodeling, and translational strategies remain limited. This review summarizes the classification and epidemiological characteristics of major oncogenic viruses, including human papillomavirus (HPV), Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), Merkel cell polyomavirus (MCPyV), human T-lymphotropic virus type 1 (HTLV-1), Kaposi\u2019s sarcoma-associated herpesvirus (KSHV), and human immunodeficiency virus (HIV), as well as emerging viruses such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We then discuss the molecular basis of virus-associated carcinogenesis, including viral oncogenes, viral DNA integration, epigenetic remodeling, aberrant host signaling, and metabolic dysregulation. We further examine how chronic inflammation and fibrosis create oncogenic niches within the tumor microenvironment (TME), how viruses promote tumor progression through immune evasion and immune exhaustion, and how infected cells interact with stromal and immune components of the TME. At the preventive and therapeutic levels, we discuss antiviral therapies, vaccines, biomarker-based precision diagnostics, and prognostic strategies, with particular attention to the synergistic potential of emerging therapeutic approaches such as immune checkpoint inhibitors (ICIs), CAR-T therapy, and oncolytic viruses (OVs). Finally, we highlight how multi-omics approaches, single-cell transcriptomics, spatial transcriptomics, organoid models, and artificial intelligence can advance mechanistic studies and translational innovation in virus-associated cancers. Overall, this review provides an integrated framework for understanding, preventing, and treating virus-associated tumorigenesis.<\/jats:p>","DOI":"10.1186\/s43556-026-00485-6","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:35:20Z","timestamp":1783492520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Virus infections and cancers: from mechanisms to therapeutics"],"prefix":"10.1186","volume":"7","author":[{"given":"Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huancheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaolin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9735-2007","authenticated-orcid":false,"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"5","key":"485_CR1","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1084\/jem.150.4.729","volume":"12","author":"P Rous","year":"1910","unstructured":"Rous P. A transmissible avian neoplasm. (sarcoma of the common fowl). J Exp Med. 1910;12(5):696\u2013705. https:\/\/doi.org\/10.1084\/jem.150.4.729.","journal-title":"J Exp Med"},{"key":"485_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1333812","volume":"13","author":"R Ye","year":"2023","unstructured":"Ye R, Wang A, Bu B, Luo P, Deng W, Zhang X, et al. Viral oncogenes, viruses, and cancer: a third-generation sequencing perspective on viral integration into the human genome. Front Oncol. 2023;13:1333812. https:\/\/doi.org\/10.3389\/fonc.2023.1333812.","journal-title":"Front Oncol"},{"issue":"10504","key":"485_CR3","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","volume":"406","author":"SL Chan","year":"2025","unstructured":"Chan SL, Sun HC, Xu Y, Zeng H, El-Serag HB, Lee JM, et al. The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment. Lancet. 2025;406(10504):731\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(25)01042-6.","journal-title":"Lancet"},{"issue":"2","key":"485_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/ijc.35369","volume":"157","author":"Z Li","year":"2025","unstructured":"Li Z, Liu P, Yin A, Zhang B, Xu J, Chen Z, et al. Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: the urgent need to address inequalities in cervical cancer. Int J Cancer. 2025;157(2):288\u201397. https:\/\/doi.org\/10.1002\/ijc.35369.","journal-title":"Int J Cancer"},{"issue":"8080","key":"485_CR5","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-025-09332-0","volume":"645","author":"SB Chia","year":"2025","unstructured":"Chia SB, Johnson BJ, Hu J, Valen\u00e7a-Pereira F, Chadeau-Hyam M, Guntoro F, et al. Respiratory viral infections awaken metastatic breast cancer cells in lungs. Nature. 2025;645(8080):496\u2013506. https:\/\/doi.org\/10.1038\/s41586-025-09332-0.","journal-title":"Nature"},{"issue":"3","key":"485_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"485_CR7","doi-asserted-by":"publisher","unstructured":"Gargano JW, Stefanos R, Dahl RM, Castilho JL, Bostick EA, Niccolai LM, et al. Trends in Cervical Precancers Identified Through Population-Based Surveillance - Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008\u20132022. MMWR Morb Mortal Wkly Rep. 2025;74(6):96\u2013101. https:\/\/doi.org\/10.15585\/mmwr.mm7406a.","DOI":"10.15585\/mmwr.mm7406a"},{"issue":"2","key":"485_CR8","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/s2214-109x(19)30488-7","volume":"8","author":"C De Martel","year":"2020","unstructured":"De Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180\u201390. https:\/\/doi.org\/10.1016\/s2214-109x(19)30488-7.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"485_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1053\/j.seminoncol.2014.10.003","volume":"41","author":"H Zur Hausen","year":"2014","unstructured":"Zur Hausen H, De Villiers EM. Cancer \u201cCausation\u201d by infections--individual contributions and synergistic networks. Semin Oncol. 2014;41(6):860\u201375. https:\/\/doi.org\/10.1053\/j.seminoncol.2014.10.003.","journal-title":"Semin Oncol"},{"key":"485_CR10","doi-asserted-by":"publisher","unstructured":"Tempera I, Lieberman PM. Oncogenic viruses as entropic drivers of cancer evolution. Front Virol. 2021;1: 753366. https:\/\/doi.org\/10.3389\/fviro.2021.753366.","DOI":"10.3389\/fviro.2021.753366"},{"issue":"Suppl 1(Suppl 1","key":"485_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA Mcglynn","year":"2021","unstructured":"Mcglynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73(Suppl 1(Suppl 1)):4\u201313. https:\/\/doi.org\/10.1002\/hep.31288.","journal-title":"Hepatology"},{"issue":"Suppl","key":"485_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/jog.15943","volume":"50","author":"Y Ueda","year":"2024","unstructured":"Ueda Y. Epidemiology of cervical cancer and HPV infection in Asia and Oceania. J Obstet Gynaecol Res. 2024;50(Suppl):131\u201341. https:\/\/doi.org\/10.1111\/jog.15943.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"485_CR13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.semradonc.2021.04.001","volume":"31","author":"N Scott-Wittenborn","year":"2021","unstructured":"Scott-Wittenborn N, Fakhry C. Epidemiology of HPV related malignancies. Semin Radiat Oncol. 2021;31(4):286\u201396. https:\/\/doi.org\/10.1016\/j.semradonc.2021.04.001.","journal-title":"Semin Radiat Oncol"},{"issue":"4","key":"485_CR14","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","volume":"141","author":"C De Martel","year":"2017","unstructured":"De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664\u201370. https:\/\/doi.org\/10.1002\/ijc.30716.","journal-title":"Int J Cancer"},{"key":"485_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1455931","author":"Y Kou","year":"2024","unstructured":"Kou Y, Tang X, Liang D, Xie C, Zeng J, Chen M, et al. HPV genotypes in invasive cervical cancer: Prevalence, risk attribution, and optimized vaccine strategies in Western China. Front Public Health. 2024. https:\/\/doi.org\/10.3389\/fpubh.2024.1455931.","journal-title":"Front Public Health"},{"key":"485_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ypmed.2016.12.029","volume":"98","author":"M Maza","year":"2017","unstructured":"Maza M, Gage JC. Considerations for HPV primary screening in lower-middle income countries. Prev Med. 2017;98:39\u201341. https:\/\/doi.org\/10.1016\/j.ypmed.2016.12.029.","journal-title":"Prev Med"},{"issue":"7","key":"485_CR17","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1016\/s2468-2667(21)00046-3","volume":"6","author":"M Bonjour","year":"2021","unstructured":"Bonjour M, Charvat H, Franco EL, Pi\u00f1eros M, Clifford GM, Bray F, et al. Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. Lancet Public Health. 2021;6(7):e510\u201321. https:\/\/doi.org\/10.1016\/s2468-2667(21)00046-3.","journal-title":"Lancet Public Health"},{"issue":"4","key":"485_CR18","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/cas.13954","volume":"110","author":"T Kanda","year":"2019","unstructured":"Kanda T, Yajima M, Ikuta K. Epstein-Barr Virus strain variation and cancer. Cancer Sci. 2019;110(4):1132\u20139. https:\/\/doi.org\/10.1111\/cas.13954.","journal-title":"Cancer Sci"},{"issue":"4","key":"485_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2478\/rjim-2020-0017","volume":"58","author":"N Iftode","year":"2020","unstructured":"Iftode N, R\u0103dulescu MA, Aram\u0103 \u0218S, Aram\u0103 V. Update on Kaposi Sarcoma-Associated Herpesvirus (KSHV or HHV8) - review. Rom J Intern Med. 2020;58(4):199\u2013208. https:\/\/doi.org\/10.2478\/rjim-2020-0017.","journal-title":"Rom J Intern Med"},{"issue":"9","key":"485_CR20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1086\/592298","volume":"47","author":"RJ Sullivan","year":"2008","unstructured":"Sullivan RJ, Pantanowitz L, Casper C, Stebbing J, Dezube BJ. HIV\/AIDS: epidemiology, pathophysiology, and treatment of Kaposi Sarcoma-Associated Herpesvirus Disease: Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease. Clin Infect Dis. 2008;47(9):1209\u201315. https:\/\/doi.org\/10.1086\/592298.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"485_CR21","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/17474124.2021.1991792","volume":"15","author":"P Konyn","year":"2021","unstructured":"Konyn P, Ahmed A, Kim D. Current epidemiology in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2021;15(11):1295\u2013307. https:\/\/doi.org\/10.1080\/17474124.2021.1991792.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"8","key":"485_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"YC Hsu","year":"2023","unstructured":"Hsu YC, Huang DQ, Nguyen MH. Global burden of Hepatitis B Virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20(8):524\u201337. https:\/\/doi.org\/10.1038\/s41575-023-00760-9.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"Suppl","key":"485_CR23","doi-asserted-by":"publisher","first-page":"S228","DOI":"10.3350\/cmh.2024.0824","volume":"31","author":"SY Hwang","year":"2025","unstructured":"Hwang SY, Danpanichkul P, Agopian V, Mehta N, Parikh ND, Abou-Alfa GK, et al. Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment. Clin Mol Hepatol. 2025;31(Suppl):S228\u201354. https:\/\/doi.org\/10.3350\/cmh.2024.0824.","journal-title":"Clin Mol Hepatol"},{"issue":"8","key":"485_CR24","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1111\/liv.14821","volume":"41","author":"C Li","year":"2021","unstructured":"Li C, He WQ. The impact of universal Hepatitis B vaccine on the trend of liver cancer from the Global Burden of Disease Study 2017. Liver Int. 2021;41(8):1762\u201374. https:\/\/doi.org\/10.1111\/liv.14821.","journal-title":"Liver Int"},{"issue":"3","key":"485_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cnc.2022.04.004","volume":"34","author":"H Gilles","year":"2022","unstructured":"Gilles H, Garbutt T, Landrum J. Hepatocellular carcinoma. Crit Care Nurs Clin North Am. 2022;34(3):289\u2013301. https:\/\/doi.org\/10.1016\/j.cnc.2022.04.004.","journal-title":"Crit Care Nurs Clin North Am"},{"issue":"Suppl 1","key":"485_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/liv.13659","volume":"38","author":"B Roche","year":"2018","unstructured":"Roche B, Coilly A, Duclos-Vallee JC, Samuel D. The impact of treatment of Hepatitis C with Daas on the occurrence of HCC. Liver Int. 2018;38(Suppl 1):139\u201345. https:\/\/doi.org\/10.1111\/liv.13659.","journal-title":"Liver Int"},{"key":"485_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvr.2021.200232","volume":"13","author":"JF Yang","year":"2022","unstructured":"Yang JF, You J. Merkel Cell Polyomavirus and associated Merkel Cell Carcinoma. Tumour Virus Research. 2022;13:200232. https:\/\/doi.org\/10.1016\/j.tvr.2021.200232.","journal-title":"Tumour Virus Research"},{"key":"485_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.739695","volume":"12","author":"NA Krump","year":"2021","unstructured":"Krump NA, You J. From Merkel Cell Polyomavirus infection to Merkel Cell Carcinoma oncogenesis. Front Microbiol. 2021;12:739695. https:\/\/doi.org\/10.3389\/fmicb.2021.739695.","journal-title":"Front Microbiol"},{"key":"485_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01425","volume":"8","author":"Y Tagaya","year":"2017","unstructured":"Tagaya Y, Gallo RC. The exceptional oncogenicity of HTLV-1. Front Microbiol. 2017;8:1425. https:\/\/doi.org\/10.3389\/fmicb.2017.01425.","journal-title":"Front Microbiol"},{"key":"485_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388. https:\/\/doi.org\/10.3389\/fmicb.2012.00388.","journal-title":"Front Microbiol"},{"issue":"3","key":"485_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s11904-005-0008-4","volume":"2","author":"ST Lim","year":"2005","unstructured":"Lim ST, Levine AM. Non-Aids-Defining cancers and HIV infection. Curr HIV\/AIDS Rep. 2005;2(3):146\u201353. https:\/\/doi.org\/10.1007\/s11904-005-0008-4.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"10425","key":"485_CR32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/s0140-6736(23)01381-8","volume":"403","author":"A Mody","year":"2024","unstructured":"Mody A, Sohn AH, Iwuji C, Tan RKJ, Venter F, Geng EH. HIV epidemiology, prevention, treatment, and implementation strategies for public health. Lancet. 2024;403(10425):471\u201392. https:\/\/doi.org\/10.1016\/s0140-6736(23)01381-8.","journal-title":"Lancet"},{"issue":"1","key":"485_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00914-z","volume":"9","author":"FC Mariz","year":"2024","unstructured":"Mariz FC, Banks L, Ottonello S, M\u00fcller M. A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity. NPJ Vaccines. 2024;9(1):119. https:\/\/doi.org\/10.1038\/s41541-024-00914-z.","journal-title":"NPJ Vaccines"},{"issue":"22","key":"485_CR34","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1158\/1078-0432.Ccr-22-1927","volume":"28","author":"P Hillemanns","year":"2022","unstructured":"Hillemanns P, Denecke A, Woelber L, B\u00f6hmer G, Jentschke M, Schjetne KW, et al. A therapeutic antigen-presenting cell-targeting DNA vaccine Vb10.16 in HPV16-positive high-grade cervical intraepithelial neoplasia: Results from a phase I\/IIa trial. Clin Cancer Res. 2022;28(22):4885\u201392. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-22-1927.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"485_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ijrobp.2020.02.031","volume":"107","author":"Y Hasan","year":"2020","unstructured":"Hasan Y, Furtado L, Tergas A, Lee N, Brooks R, Mccall A, et al. A Phase 1 trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6\/E7 oncogenes after chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys. 2020;107(3):487\u201398. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.02.031.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"485_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867918","volume":"13","author":"GM Escalante","year":"2022","unstructured":"Escalante GM, Mutsvunguma LZ, Muniraju M, Rodriguez E, Ogembo JG. Four decades of prophylactic EBV vaccine research: a systematic review and historical perspective. Front Immunol. 2022;13:867918. https:\/\/doi.org\/10.3389\/fimmu.2022.867918.","journal-title":"Front Immunol"},{"issue":"30","key":"485_CR37","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1016\/j.vaccine.2019.04.071","volume":"37","author":"DH Mulama","year":"2019","unstructured":"Mulama DH, Mutsvunguma LZ, Totonchy J, Ye P, Foley J, Escalante GM, et al. A multivalent Kaposi Sarcoma-Associated Herpesvirus-Like Particle Vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits. Vaccine. 2019;37(30):4184\u201394. https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.071.","journal-title":"Vaccine"},{"issue":"21","key":"485_CR38","doi-asserted-by":"publisher","first-page":"34481","DOI":"10.18632\/oncotarget.15605","volume":"8","author":"AK Barasa","year":"2017","unstructured":"Barasa AK, Ye P, Phelps M, Arivudainambi GT, Tison T, Ogembo JG. Balb\/C mice immunized with a combination of virus-like particles incorporating Kaposi Sarcoma-associated herpesvirus (KSHV) envelope glycoproteins Gpk8.1, Gb, and Gh\/Gl induced comparable serum neutralizing antibody activity to Uv-inactivated KSHV. Oncotarget. 2017;8(21):34481\u201397. https:\/\/doi.org\/10.18632\/oncotarget.15605.","journal-title":"Oncotarget"},{"issue":"1","key":"485_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/j.gastro.2019.03.044","volume":"157","author":"C Boni","year":"2019","unstructured":"Boni C, Janssen HLA, Rossi M, Yoon SK, Vecchi A, Barili V, et al. Combined Gs-4774 and Tenofovir therapy can improve HBV-specific T-cell responses in patients with Chronic Hepatitis. Gastroenterology. 2019;157(1):227-241.e7. https:\/\/doi.org\/10.1053\/j.gastro.2019.03.044.","journal-title":"Gastroenterology"},{"issue":"1","key":"485_CR40","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/hep.32109","volume":"75","author":"L Wei","year":"2022","unstructured":"Wei L, Zhao T, Zhang J, Mao Q, Gong G, Sun Y, et al. Efficacy and safety of a nanoparticle therapeutic vaccine in patients with Chronic Hepatitis B: a randomized clinical trial. Hepatology. 2022;75(1):182\u201395. https:\/\/doi.org\/10.1002\/hep.32109.","journal-title":"Hepatology"},{"issue":"3","key":"485_CR41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/hepr.13851","volume":"53","author":"O Yoshida","year":"2023","unstructured":"Yoshida O, Akbar SMF, Imai Y, Sanada T, Tsukiyama-Kohara K, Miyazaki T, et al. Intranasal therapeutic vaccine containing HBsAg and HBcAg for patients with Chronic Hepatitis B; 18 months follow-up results of Phase IIa clinical study. Hepatol Res. 2023;53(3):196\u2013207. https:\/\/doi.org\/10.1111\/hepr.13851.","journal-title":"Hepatol Res"},{"issue":"2","key":"485_CR42","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1053\/j.gastro.2018.08.060","volume":"156","author":"JR Bailey","year":"2019","unstructured":"Bailey JR, Barnes E, Cox AL. Approaches, progress, and challenges to Hepatitis C vaccine development. Gastroenterology. 2019;156(2):418\u201330. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.060.","journal-title":"Gastroenterology"},{"issue":"6","key":"485_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1056\/NEJMoa2023345","volume":"384","author":"K Page","year":"2021","unstructured":"Page K, Melia MT, Veenhuis RT, Winter M, Rousseau KE, Massaccesi G, et al. Randomized trial of a vaccine regimen to prevent chronic HCV infection. N Engl J Med. 2021;384(6):541\u20139. https:\/\/doi.org\/10.1056\/NEJMoa2023345.","journal-title":"N Engl J Med"},{"issue":"1","key":"485_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jhep.2020.02.009","volume":"73","author":"JW Han","year":"2020","unstructured":"Han JW, Sung PS, Hong SH, Lee H, Koh JY, Lee H, et al. Ifnl3-Adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responses. J Hepatol. 2020;73(1):72\u201383. https:\/\/doi.org\/10.1016\/j.jhep.2020.02.009.","journal-title":"J Hepatol"},{"issue":"7","key":"485_CR45","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/mc.23190","volume":"59","author":"S Tabachnick-Cherny","year":"2020","unstructured":"Tabachnick-Cherny S, Pulliam T, Church C, Koelle DM, Nghiem P. Polyomavirus-Driven Merkel Cell Carcinoma: prospects for therapeutic vaccine development. Mol Carcinog. 2020;59(7):807\u201321. https:\/\/doi.org\/10.1002\/mc.23190.","journal-title":"Mol Carcinog"},{"issue":"1-2","key":"485_CR46","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ijpharm.2018.07.069","volume":"549","author":"M Kabiri","year":"2018","unstructured":"Kabiri M, Sankian M, Hosseinpour M, Tafaghodi M. The novel immunogenic chimeric peptide vaccine to elicit potent cellular and mucosal immune responses against HTLV-1. Int J Pharm. 2018;549(1\u20132):404\u201314. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.07.069.","journal-title":"Int J Pharm"},{"key":"485_CR47","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1146\/annurev-immunol-080219-023629","volume":"38","author":"KE Stephenson","year":"2020","unstructured":"Stephenson KE, Wagh K, Korber B, Barouch DH. Vaccines and broadly neutralizing antibodies for HIV-1 prevention. Annu Rev Immunol. 2020;38:673\u2013703. https:\/\/doi.org\/10.1146\/annurev-immunol-080219-023629.","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"485_CR48","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","volume":"384","author":"S Edupuganti","year":"2021","unstructured":"Edupuganti S, Mgodi NM, Decamp AC, Rudnicki E, Huang Y, Gonzales P, et al. Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition. N Engl J Med. 2021;384(11):1003\u201314. https:\/\/doi.org\/10.1056\/NEJMoa2031738.","journal-title":"N Engl J Med"},{"issue":"4","key":"485_CR49","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.gendis.2022.09.014","volume":"10","author":"M Mann","year":"2023","unstructured":"Mann M, Singh VP, Kumar L. Cervical cancer: a tale from HPV infection to PARP inhibitors. Genes Dis. 2023;10(4):1445\u201356. https:\/\/doi.org\/10.1016\/j.gendis.2022.09.014.","journal-title":"Genes Dis"},{"issue":"22","key":"485_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225706","volume":"14","author":"S Oldani","year":"2022","unstructured":"Oldani S, Petrelli F, Dognini G, Borgonovo K, Parati MC, Ghilardi M, et al. COVID-19 and lung cancer survival: an updated systematic review and meta-analysis. Cancers Basel. 2022;14(22):5706. https:\/\/doi.org\/10.3390\/cancers14225706.","journal-title":"Cancers Basel"},{"issue":"3","key":"485_CR51","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","volume":"21","author":"W Liang","year":"2020","unstructured":"Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335\u20137. https:\/\/doi.org\/10.1016\/S1470-2045(20)30096-6.","journal-title":"Lancet Oncol"},{"issue":"1","key":"485_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-04237-1","volume":"23","author":"V Trimarco","year":"2025","unstructured":"Trimarco V, Izzo R, Pacella D, Manzi MV, Varzideh F, Lembo M, et al. The COVID-19 pandemic increased the incidence of newly diagnosed cancers: evidence from a large cohort study in Southern Italy. BMC Med. 2025;23(1):399. https:\/\/doi.org\/10.1186\/s12916-025-04237-1.","journal-title":"BMC Med"},{"issue":"1","key":"485_CR53","doi-asserted-by":"publisher","first-page":"18978","DOI":"10.1038\/s41598-022-23047-6","volume":"12","author":"M Zureik","year":"2022","unstructured":"Zureik M, Blanchin M, Bouvier A, Le Goff J, Luccioni M, Mesbah M, et al. Severe SARS-CoV-2 infection and risk of subsequent diagnosis of cancer: a population-based cohort study. Sci Rep. 2022;12(1):18978. https:\/\/doi.org\/10.1038\/s41598-022-23047-6.","journal-title":"Sci Rep"},{"issue":"2","key":"485_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/v14020427","volume":"14","author":"C Prezioso","year":"2022","unstructured":"Prezioso C, Brazzini G, Passerini S, Di Fabio C, Cosio T, Bernardini S, et al. Prevalence of MCPyV, HPyV6, HPyV7 and TSPyV in actinic keratosis biopsy specimens. Viruses. 2022;14(2):427. https:\/\/doi.org\/10.3390\/v14020427.","journal-title":"Viruses"},{"issue":"4","key":"485_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.70048","volume":"35","author":"A Kausar","year":"2025","unstructured":"Kausar A, Amraiz D, Ali L, Fatima M. A systematic review of BK and JC polyomaviruses in Asia: molecular insights and prevalence. Rev Med Virol. 2025;35(4):e70048. https:\/\/doi.org\/10.1002\/rmv.70048.","journal-title":"Rev Med Virol"},{"issue":"8","key":"485_CR56","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/apm.12125","volume":"121","author":"CH Rinaldo","year":"2013","unstructured":"Rinaldo CH, Hirsch HH. The human polyomaviruses: from orphans and mutants to patchwork family. APMIS. 2013;121(8):681\u20134. https:\/\/doi.org\/10.1111\/apm.12125.","journal-title":"APMIS"},{"issue":"suppl 1","key":"485_CR57","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2018\/e558s","volume":"73","author":"JCM Prado","year":"2018","unstructured":"Prado JCM, Monezi TA, Amorim AT, Lino V, Paladino A, Boccardo E. Human polyomaviruses and cancer: an overview. Clinics Sao Paulo. 2018;73(suppl 1):e558s. https:\/\/doi.org\/10.6061\/clinics\/2018\/e558s.","journal-title":"Clinics Sao Paulo"},{"key":"485_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2025.101383","volume":"104","author":"Q Wu","year":"2025","unstructured":"Wu Q, Li W, Liu H, Xue Y, Huang K, Pourghadamyari H, et al. Respiratory emerging viruses and drug resistance in lung cancer: challenges and new perspectives in treatment. Mol Aspects Med. 2025;104:101383. https:\/\/doi.org\/10.1016\/j.mam.2025.101383.","journal-title":"Mol Aspects Med"},{"issue":"6","key":"485_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/tid.70113","volume":"27","author":"T Shafat","year":"2025","unstructured":"Shafat T, Spallone A, Khawaja F, Jackson J, Nesher L, Chemaly RF. Respiratory syncytial virus exceeded SARS-CoV-2 and influenza in lower respiratory infection and mortality rates among patients with hematologic malignancies during the 2023-2024 respiratory virus season. Transplant Infect Dis. 2025;27(6):e70113. https:\/\/doi.org\/10.1111\/tid.70113.","journal-title":"Transplant Infect Dis"},{"issue":"23","key":"485_CR60","doi-asserted-by":"publisher","first-page":"7237","DOI":"10.1007\/s00018-021-03957-w","volume":"78","author":"E Elshina","year":"2021","unstructured":"Elshina E, Te Velthuis AJW. The influenza virus RNA polymerase as an innate immune agonist and antagonist. Cell Mol Life Sci. 2021;78(23):7237\u201356. https:\/\/doi.org\/10.1007\/s00018-021-03957-w.","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"485_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(03)00856-9","volume":"14","author":"DB Di Giulio","year":"2022","unstructured":"Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2022;14(11):e31736. https:\/\/doi.org\/10.1016\/s1473-3099(03)00856-9.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"485_CR62","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1056\/NEJMoa2207323","volume":"387","author":"JP Thornhill","year":"2022","unstructured":"Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox virus infection in humans across 16 countries - April-June 2022. N Engl J Med. 2022;387(8):679\u201391. https:\/\/doi.org\/10.1056\/NEJMoa2207323.","journal-title":"N Engl J Med"},{"issue":"10","key":"485_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14101047","volume":"14","author":"G Martelossi-Cebinelli","year":"2025","unstructured":"Martelossi-Cebinelli G, Carneiro JA, Yaekashi KM, Bertozzi MM, Bianchini BHS, Rasquel-Oliveira FS, et al. A review of the biology of Chikungunya virus highlighting the development of current novel therapeutic and prevention approaches. Pathogens. 2025;14(10):1047. https:\/\/doi.org\/10.3390\/pathogens14101047.","journal-title":"Pathogens"},{"issue":"9","key":"485_CR64","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.3390\/ijms23095050","volume":"23","author":"M L\u00e4sche","year":"2022","unstructured":"L\u00e4sche M, Gallwas J, Gr\u00fcndker C. Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer. Int J Mol Sci. 2022;23(9):5050. https:\/\/doi.org\/10.3390\/ijms23095050.","journal-title":"Int J Mol Sci"},{"key":"485_CR65","doi-asserted-by":"publisher","first-page":"1356581","DOI":"10.3389\/fonc.2024.1356581","volume":"14","author":"V Vallejo-Ruiz","year":"2024","unstructured":"Vallejo-Ruiz V, Guti\u00e9rrez-Xicotencatl L, Medina-Contreras O, Lizano M. Molecular aspects of cervical cancer: a pathogenesis update. Front Oncol. 2024;14:1356581. https:\/\/doi.org\/10.3389\/fonc.2024.1356581.","journal-title":"Front Oncol"},{"key":"485_CR66","doi-asserted-by":"publisher","unstructured":"Yuan L, Wang Y, Yu M, Feng Z, Ci M, Wang C, et al. Oncogenic HPV-induced high expression of ESM1 predicts poor prognosis and regulates aerobic glycolysis in cervical cancer. iScience. 2024;27(6):110112. https:\/\/doi.org\/10.1016\/j.isci.2024.110112.","DOI":"10.1016\/j.isci.2024.110112"},{"issue":"9","key":"485_CR67","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/vaccines13090911","volume":"13","author":"CS Ng","year":"2025","unstructured":"Ng CS. Immunotherapy of Oncovirus-Induced Cancers: A Review on the Development and Efficacy of Targeted Vaccines. Vaccines. 2025;13(9):911. https:\/\/doi.org\/10.3390\/vaccines13090911.","journal-title":"Vaccines"},{"issue":"8","key":"485_CR68","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1158\/1541-7786.MCR-20-0884","volume":"19","author":"J Aldersley","year":"2021","unstructured":"Aldersley J, Lorenz DR, Mouw KW, D\u2019Andrea AD, Gabuzda D. Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes. Mol Cancer Res. 2021;19(8):1308\u201321. https:\/\/doi.org\/10.1158\/1541-7786.MCR-20-0884.","journal-title":"Mol Cancer Res"},{"issue":"10","key":"485_CR69","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.3390\/v17101344","volume":"17","author":"K Tamai","year":"2025","unstructured":"Tamai K, Kinjo S, Taguchi A, Nagasaka K, Yoshimoto D, Duong AQ, et al. Elucidating Alterations in Viral and Human Gene Expression Due to Human Papillomavirus Integration by Using Multimodal RNA Sequencing. Viruses. 2025;17(10):1344. https:\/\/doi.org\/10.3390\/v17101344.","journal-title":"Viruses"},{"issue":"3","key":"485_CR70","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.livres.2025.09.002","volume":"9","author":"L Ma","year":"2025","unstructured":"Ma L, Chen S, Wang H, Chen L. Hepatitis B virus integration and hepatocarcinogenesis. Liver Res. 2025;9(3):189\u201398. https:\/\/doi.org\/10.1016\/j.livres.2025.09.002.","journal-title":"Liver Res"},{"issue":"Pt 12","key":"485_CR71","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1099\/vir.0.83214-0","volume":"88","author":"J Pan","year":"2007","unstructured":"Pan J, Lian Z, Wallet S, Feitelson MA. The hepatitis B x antigen effector, URG7, blocks tumour necrosis factor alpha-mediated apoptosis by activation of phosphoinositol 3-kinase and beta-catenin. J Gen Virol. 2007;88(Pt 12):3275\u201385. https:\/\/doi.org\/10.1099\/vir.0.83214-0.","journal-title":"J Gen Virol"},{"key":"485_CR72","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1743-422X-9-163","volume":"9","author":"R Tang","year":"2012","unstructured":"Tang R, Kong F, Hu L, You H, Zhang P, Du W, et al. Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells. Virology journal. 2012;9:163. https:\/\/doi.org\/10.1186\/1743-422X-9-163.","journal-title":"Virology journal"},{"issue":"6","key":"485_CR73","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/medicina60060872","volume":"60","author":"I Iordan","year":"2024","unstructured":"Iordan I, Vl\u0103d\u0103reanu AM, Mambet C, Onis\u00e2i M, C\u00ee\u0219leanu D, Bumbea H. Clinical Features and Survival Outcome in Aggressive-Type Adult T-Cell Leukemia\/Lymphoma Patients: Real-Life Experience of a Single Center from an HTLV-1 Endemic Country. Medicina (Kaunas). 2024;60(6):872. https:\/\/doi.org\/10.3390\/medicina60060872.","journal-title":"Medicina (Kaunas)"},{"issue":"26","key":"485_CR74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2420756122","volume":"122","author":"W Zhang","year":"2025","unstructured":"Zhang W, Shichijo T, Chen X, Watanabe M, Nosaka K, Matsuoka M, et al. JunB-HBZ nuclear translocation by TGF-\u03b2 is a key driver in HTLV-1-mediated leukemogenesis. Proc Natl Acad Sci U S A. 2025;122(26):e2420756122. https:\/\/doi.org\/10.1073\/pnas.2420756122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"485_CR75","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/978-3-030-57362-1_10","volume":"217","author":"CZ Giam","year":"2021","unstructured":"Giam CZ. HTLV-1 Replication and Adult T Cell Leukemia Development. Recent Results Cancer Res. 2021;217:209\u201343. https:\/\/doi.org\/10.1007\/978-3-030-57362-1_10.","journal-title":"Recent Results Cancer Res"},{"issue":"1","key":"485_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v10010001","volume":"10","author":"N Futsch","year":"2017","unstructured":"Futsch N, Mahieux R, Dutartre H. HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment. Viruses. 2017;10(1):1. https:\/\/doi.org\/10.3390\/v10010001.","journal-title":"Viruses"},{"key":"485_CR77","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuaf048","volume":"49","author":"Y Sato","year":"2025","unstructured":"Sato Y, Okuno Y, Murata T, Kimura H. Defective but tumorigenic: the evolutionary and functional roles of mutated oncoviruses. FEMS Microbiol Rev. 2025;49:fuaf048. https:\/\/doi.org\/10.1093\/femsre\/fuaf048.","journal-title":"FEMS Microbiol Rev"},{"issue":"11","key":"485_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010524","volume":"18","author":"JC Santiago","year":"2022","unstructured":"Santiago JC, Adams SV, Towlerton A, Okuku F, Phipps W, Mullins JI. Genomic changes in Kaposi Sarcoma-associated Herpesvirus and their clinical correlates. PLoS Pathog. 2022;18(11):e1010524. https:\/\/doi.org\/10.1371\/journal.ppat.1010524.","journal-title":"PLoS Pathog"},{"issue":"21","key":"485_CR79","doi-asserted-by":"publisher","first-page":"6574","DOI":"10.3390\/jcm11216574","volume":"11","author":"HE Leroyer","year":"2022","unstructured":"Leroyer HE, Ziegler C, Moulin C, Campidelli A, Jacquet C, Rubio MT, et al. Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed\/Refractory Hodgkin Lymphoma. J Clin Med. 2022;11(21):6574. https:\/\/doi.org\/10.3390\/jcm11216574.","journal-title":"J Clin Med"},{"issue":"10","key":"485_CR80","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41579-025-01181-y","volume":"23","author":"C M\u00fcnz","year":"2025","unstructured":"M\u00fcnz C. Epstein-Barr virus pathogenesis and emerging control strategies. Nat Rev Microbiol. 2025;23(10):667\u201379. https:\/\/doi.org\/10.1038\/s41579-025-01181-y.","journal-title":"Nat Rev Microbiol"},{"issue":"13","key":"485_CR81","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/blood.2024028055","volume":"146","author":"HT Khine","year":"2025","unstructured":"Khine HT, Sato Y, Hamada M, Umeda M, Iizuka A, Son S, et al. Association of Epstein-Barr virus genomic alterations with human pathologies. Blood. 2025;146(13):1533\u201345. https:\/\/doi.org\/10.1182\/blood.2024028055.","journal-title":"Blood"},{"issue":"1","key":"485_CR82","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1001\/jamaoncol.2022.5357","volume":"9","author":"Z Bakouny","year":"2023","unstructured":"Bakouny Z, Labaki C, Grover P, Awosika J, Gulati S, Hsu CY, et al. Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19. JAMA Oncol. 2023;9(1):128\u201334. https:\/\/doi.org\/10.1001\/jamaoncol.2022.5357.","journal-title":"JAMA Oncol"},{"issue":"8","key":"485_CR83","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70565","volume":"97","author":"Q Wan","year":"2025","unstructured":"Wan Q, Tucker AJ, Zhao J. Oncogenic Mechanisms of Kaposi\u2019s Sarcoma-Associated Herpesvirus on Cell Metabolism and Cell Transformation. J Med Virol. 2025;97(8):e70565. https:\/\/doi.org\/10.1002\/jmv.70565.","journal-title":"J Med Virol"},{"issue":"9","key":"485_CR84","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00266-25","volume":"99","author":"A Nguyen","year":"2025","unstructured":"Nguyen A, Li T, Traugot C, Paulsen K, Nelson TS, Xie M, et al. Essential function of the integrator complex in Kaposi\u2019s sarcoma-associated herpesvirus lytic replication. J Virol. 2025;99(9):e0026625. https:\/\/doi.org\/10.1128\/jvi.00266-25.","journal-title":"J Virol"},{"issue":"1","key":"485_CR85","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41392-025-02197-9","volume":"10","author":"Q Xiao","year":"2025","unstructured":"Xiao Q, Liu Y, Li T, Wang C, He S, Zhai L, et al. Viral oncogenesis in cancer: from mechanisms to therapeutics. Signal Transduct Target Ther. 2025;10(1):151. https:\/\/doi.org\/10.1038\/s41392-025-02197-9.","journal-title":"Signal Transduct Target Ther"},{"issue":"40","key":"485_CR86","doi-asserted-by":"publisher","first-page":"6214","DOI":"10.1038\/sj.onc.1206637","volume":"22","author":"G De Falco","year":"2003","unstructured":"De Falco G, Bellan C, Lazzi S, Claudio P, La Sala D, Cinti C, et al. Interaction between HIV-1 Tat and pRb2\/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms. Oncogene. 2003;22(40):6214\u20139. https:\/\/doi.org\/10.1038\/sj.onc.1206637.","journal-title":"Oncogene"},{"issue":"36","key":"485_CR87","doi-asserted-by":"publisher","first-page":"14580","DOI":"10.1073\/pnas.1206605109","volume":"109","author":"F Caccuri","year":"2012","unstructured":"Caccuri F, Giagulli C, Bugatti A, Benetti A, Alessandri G, Ribatti D, et al. HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2. Proc Natl Acad Sci U S A. 2012;109(36):14580\u20135. https:\/\/doi.org\/10.1073\/pnas.1206605109.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"485_CR88","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.1074\/jbc.M107322200","volume":"277","author":"JA Schrager","year":"2002","unstructured":"Schrager JA, Der Minassian V, Marsh JW. HIV Nef increases T cell ERK MAP kinase activity. J Biol Chem. 2002;277(8):6137\u201342. https:\/\/doi.org\/10.1074\/jbc.M107322200.","journal-title":"J Biol Chem"},{"key":"485_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-7-59","volume":"7","author":"G Li","year":"2010","unstructured":"Li G, Park HU, Liang D, Zhao RY. Cell cycle G2\/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R. Retrovirology. 2010;7:59. https:\/\/doi.org\/10.1186\/1742-4690-7-59.","journal-title":"Retrovirology"},{"issue":"21","key":"485_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71330","volume":"14","author":"MM Hussain","year":"2025","unstructured":"Hussain MM, Feng B, Wang JM, Zhai AQ, Li FY, Hu HJ. Recent advancements in known and emerging risk factors of hepatocellular carcinoma. Cancer Med. 2025;14(21):e71330. https:\/\/doi.org\/10.1002\/cam4.71330.","journal-title":"Cancer Med"},{"issue":"6","key":"485_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061332","volume":"10","author":"SG Kalathil","year":"2021","unstructured":"Kalathil SG, Thanavala Y. Natural killer cells and T cells in hepatocellular carcinoma and viral hepatitis: current status and perspectives for future immunotherapeutic approaches. Cells. 2021;10(6):1332. https:\/\/doi.org\/10.3390\/cells10061332.","journal-title":"Cells"},{"issue":"1","key":"485_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02083-w","volume":"10","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Qiu K, Ren J, Zhao Y, Cheng P. Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use. Signal Transduct Target Ther. 2025;10(1):44. https:\/\/doi.org\/10.1038\/s41392-024-02083-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"485_CR93","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113297","volume":"19","author":"WW Kremer","year":"2018","unstructured":"Kremer WW, van Zummeren M, Heideman DAM, Lissenberg-Witte BI, Snijders PJF, Steenbergen RDM, et al. HPV16-related cervical cancers and precancers have increased levels of host cell DNA methylation in women living with HIV. Int J Mol Sci. 2018;19(11):3297. https:\/\/doi.org\/10.3390\/ijms19113297.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"485_CR94","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35375-2","volume":"13","author":"Z Ibrahim","year":"2022","unstructured":"Ibrahim Z, Wang T, Destaing O, Salvi N, Hoghoughi N, Chabert C, et al. Structural insights into p300 regulation and acetylation-dependent genome organisation. Nat Commun. 2022;13(1):7759. https:\/\/doi.org\/10.1038\/s41467-022-35375-2.","journal-title":"Nat Commun"},{"issue":"3","key":"485_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188894","volume":"1878","author":"H Liu","year":"2023","unstructured":"Liu H, Ma H, Li Y, Zhao H. Advances in epigenetic modifications and cervical cancer research. Biochim Biophys Acta Rev Cancer. 2023;1878(3):188894. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188894.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"7-8","key":"485_CR96","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s10495-023-01840-6","volume":"28","author":"S Ranga","year":"2023","unstructured":"Ranga S, Yadav R, Chhabra R, Chauhan MB, Tanwar M, Yadav C, et al. Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives. Apoptosis. 2023;28(7\u20138):925\u201342. https:\/\/doi.org\/10.1007\/s10495-023-01840-6.","journal-title":"Apoptosis"},{"key":"485_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.886613","volume":"13","author":"R Castro-Oropeza","year":"2022","unstructured":"Castro-Oropeza R, Pi\u00f1a-S\u00e1nchez P. Epigenetic and transcriptomic regulation landscape in HPV+ cancers: biological and clinical implications. Front Genet. 2022;13:886613. https:\/\/doi.org\/10.3389\/fgene.2022.886613.","journal-title":"Front Genet"},{"key":"485_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1359766","volume":"14","author":"W Dong","year":"2024","unstructured":"Dong W, Wang H, Li M, Li P, Ji S. Virus-induced host genomic remodeling dysregulates gene expression, triggering tumorigenesis. Front Cell Infect Microbiol. 2024;14:1359766. https:\/\/doi.org\/10.3389\/fcimb.2024.1359766.","journal-title":"Front Cell Infect Microbiol"},{"key":"485_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1484455","volume":"15","author":"RK Singh","year":"2025","unstructured":"Singh RK, Vangala R, Torne AS, Bose D, Robertson ES. Epigenetic and epitranscriptomic regulation during oncogenic \u03b3-herpesvirus infection. Front Microbiol. 2025;15:1484455. https:\/\/doi.org\/10.3389\/fmicb.2024.1484455.","journal-title":"Front Microbiol"},{"issue":"7","key":"485_CR100","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1158\/1541-7786.MCR-23-0720","volume":"22","author":"Y Meng","year":"2024","unstructured":"Meng Y, Shu Z, Wang X, Hong L, Wang B, Jiang J, et al. Hepatitis B virus-mediated m6A demethylation increases hepatocellular carcinoma stemness and immune escape. Mol Cancer Res. 2024;22(7):642\u201355. https:\/\/doi.org\/10.1158\/1541-7786.MCR-23-0720.","journal-title":"Mol Cancer Res"},{"issue":"3","key":"485_CR101","doi-asserted-by":"publisher","first-page":"220","DOI":"10.14218\/JCTH.2015.00018","volume":"3","author":"K Giersch","year":"2015","unstructured":"Giersch K, Dandri M. Hepatitis B and Delta Virus: Advances on studies about interactions between the two viruses and the infected hepatocyte. J Clin Transl Hepatol. 2015;3(3):220\u20139. https:\/\/doi.org\/10.14218\/JCTH.2015.00018.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"485_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26805-8","volume":"12","author":"EG \u00c1lvarez","year":"2021","unstructured":"\u00c1lvarez EG, Demeulemeester J, Otero P, Jolly C, Garc\u00eda-Souto D, Peque\u00f1o-Valtierra A, et al. Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture. Nat Commun. 2021;12(1):6910. https:\/\/doi.org\/10.1038\/s41467-021-26805-8.","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"485_CR103","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/rmv.1823","volume":"25","author":"J Chen","year":"2015","unstructured":"Chen J. Signaling pathways in HPV-associated cancers and therapeutic implications. Rev Med Virol. 2015;25(Suppl 1):24\u201353. https:\/\/doi.org\/10.1002\/rmv.1823.","journal-title":"Rev Med Virol"},{"issue":"2","key":"485_CR104","doi-asserted-by":"publisher","DOI":"10.3892\/or.2024.8763","volume":"52","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Xie Y, Luo Y, Wang S, Han Q, Liu Q. SNAI2 enhances HPV-negative cervical cancer cell dormancy by modulating u-PAR expression and the activity of the ERK\/p38 signaling pathway in vitro. Oncol Rep. 2024;52(2):104. https:\/\/doi.org\/10.3892\/or.2024.8763.","journal-title":"Oncol Rep"},{"issue":"27","key":"485_CR105","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2300204120","volume":"120","author":"X Zhang","year":"2023","unstructured":"Zhang X, Lan Q, Zhang M, Wang F, Shi K, Li X, et al. Inhibition of AIM2 inflammasome activation by SOX\/ORF37 promotes lytic replication of Kaposi\u2019s sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A. 2023;120(27):e2300204120. https:\/\/doi.org\/10.1073\/pnas.2300204120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"485_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/v16050736","volume":"16","author":"QM Fu","year":"2024","unstructured":"Fu QM, Fang Z, Ren L, Wu QS, Zhang JB, Liu QP, et al. Partial alleviation of homologous superinfection exclusion of SeMNPV latently infected cells by G1 phase infection and G2\/M phase arrest. Viruses. 2024;16(5):736. https:\/\/doi.org\/10.3390\/v16050736.","journal-title":"Viruses"},{"issue":"1","key":"485_CR107","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/v7010116","volume":"7","author":"P Purushothaman","year":"2015","unstructured":"Purushothaman P, Uppal T, Verma SC. Molecular biology of KSHV lytic reactivation. Viruses. 2015;7(1):116\u201353. https:\/\/doi.org\/10.3390\/v7010116.","journal-title":"Viruses"},{"issue":"3","key":"485_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012082","volume":"20","author":"J Zhou","year":"2024","unstructured":"Zhou J, Wang T, Zhang H, Liu J, Wei P, Xu R, et al. KSHV vIL-6 promotes SIRT3-induced deacetylation of SERBP1 to inhibit ferroptosis and enhance cellular transformation by inducing lipoyltransferase 2 mRNA degradation. PLoS Pathog. 2024;20(3):e1012082. https:\/\/doi.org\/10.1371\/journal.ppat.1012082.","journal-title":"PLoS Pathog"},{"issue":"1","key":"485_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01793-3","volume":"21","author":"Y Luo","year":"2021","unstructured":"Luo Y, Liu Y, Wang C, Gan R. Signaling pathways of EBV-induced oncogenesis. Cancer Cell Int. 2021;21(1):93. https:\/\/doi.org\/10.1186\/s12935-021-01793-3.","journal-title":"Cancer Cell Int"},{"issue":"18","key":"485_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221810115","volume":"22","author":"R Marima","year":"2021","unstructured":"Marima R, Hull R, Lolas G, Syrigos KN, Kgoebane-Maseko M, Kaufmann AM, et al. The catastrophic HPV\/HIV dual viral oncogenomics in concert with dysregulated alternative splicing in cervical cancer. Int J Mol Sci. 2021;22(18):10115. https:\/\/doi.org\/10.3390\/ijms221810115.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"485_CR111","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1158\/0008-5472.CAN-22-3561","volume":"83","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Li L, Sha F, Lei Y, Tian X, Chen L, et al. PTTG1 reprograms asparagine metabolism to promote hepatocellular carcinoma progression. Cancer Res. 2023;83(14):2372\u201386. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3561.","journal-title":"Cancer Res"},{"issue":"4","key":"485_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2413-4","volume":"11","author":"L Ji","year":"2020","unstructured":"Ji L, Lin Z, Wan Z, Xia S, Jiang S, Cen D, et al. miR-486-3p mediates hepatocellular carcinoma sorafenib resistance by targeting FGFR4 and EGFR. Cell Death Dis. 2020;11(4):250. https:\/\/doi.org\/10.1038\/s41419-020-2413-4.","journal-title":"Cell Death Dis"},{"issue":"27","key":"485_CR113","doi-asserted-by":"publisher","first-page":"20870","DOI":"10.1074\/jbc.M110.112045","volume":"285","author":"L Peng","year":"2010","unstructured":"Peng L, Liang D, Tong W, Li J, Yuan Z. Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTOR. J Biol Chem. 2010;285(27):20870\u201381. https:\/\/doi.org\/10.1074\/jbc.M110.112045.","journal-title":"J Biol Chem"},{"issue":"6","key":"485_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/v8060152","volume":"8","author":"V Le Sage","year":"2016","unstructured":"Le Sage V, Cinti A, Amorim R, Mouland AJ. Adapting the stress response: viral subversion of the mTOR signaling pathway. Viruses. 2016;8(6):152. https:\/\/doi.org\/10.3390\/v8060152.","journal-title":"Viruses"},{"issue":"7","key":"485_CR115","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1039\/d3mo00025g","volume":"19","author":"CO Olwal","year":"2023","unstructured":"Olwal CO, Fabius JM, Zuliani-Alvarez L, Eckhardt M, Kyei GB, Quashie PK, et al. Network modeling suggests HIV infection phenocopies PI3K-AKT pathway mutations to enhance HPV-associated cervical cancer. Mol Omics. 2023;19(7):538\u201351. https:\/\/doi.org\/10.1039\/d3mo00025g.","journal-title":"Mol Omics"},{"issue":"3","key":"485_CR116","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/35004038","volume":"2","author":"V Piguet","year":"2000","unstructured":"Piguet V, Wan L, Borel C, Mangasarian A, Demaurex N, Thomas G, et al. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat Cell Biol. 2000;2(3):163\u20137. https:\/\/doi.org\/10.1038\/35004038.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"485_CR117","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/hep.510310316","volume":"31","author":"DI Tai","year":"2000","unstructured":"Tai DI, Tsai SL, Chen YM, Chuang YL, Peng CY, Sheen IS, et al. Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology. 2000;31(3):656\u201364. https:\/\/doi.org\/10.1002\/hep.510310316.","journal-title":"Hepatology"},{"key":"485_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2025.101413","volume":"106","author":"W Shen","year":"2025","unstructured":"Shen W, Guo Y, Ai C, Wang X, Li G. The double-edged sword: How SARS-CoV-2 might fuel lung cancer: Investigating the potential oncogenic mechanisms of the novel coronavirus in lung carcinogenesis. Mol Aspects Med. 2025;106:101413. https:\/\/doi.org\/10.1016\/j.mam.2025.101413.","journal-title":"Mol Aspects Med"},{"issue":"22","key":"485_CR119","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.3390\/cells11223698","volume":"11","author":"M Ra\u0161kov\u00e1","year":"2022","unstructured":"Ra\u0161kov\u00e1 M, Lacina L, Kej\u00edk Z, Venhauerov\u00e1 A, Skali\u010dkov\u00e1 M, Kol\u00e1\u0159 M, et al. The Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities. Cells. 2022;11(22):3698. https:\/\/doi.org\/10.3390\/cells11223698.","journal-title":"Cells"},{"issue":"11","key":"485_CR120","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1016\/j.immuni.2025.10.007","volume":"58","author":"Z Wang","year":"2025","unstructured":"Wang Z, Hou Y, Liu P, Wu R, Yang J, Fan S, et al. Membrane integrity changes upon viral infection activate sphingomyelinase SMPDL3B to restrict cGAS-STING signaling via cGAMP degradation. Immunity. 2025;58(11):2670-2684.e10. https:\/\/doi.org\/10.1016\/j.immuni.2025.10.007.","journal-title":"Immunity"},{"issue":"1","key":"485_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-019-1136-y","volume":"18","author":"Z Meng","year":"2019","unstructured":"Meng Z, Liu Q, Sun F, Qiao L. Hepatitis C Virus nonstructural protein 5a perturbs lipid metabolism by modulating Ampk\/Srebp-1c signaling. Lipids Health Dis. 2019;18(1):191. https:\/\/doi.org\/10.1186\/s12944-019-1136-y.","journal-title":"Lipids Health Dis"},{"issue":"24","key":"485_CR122","doi-asserted-by":"publisher","first-page":"6495","DOI":"10.1158\/1078-0432.Ccr-14-0250","volume":"20","author":"D He","year":"2014","unstructured":"He D, Xia X, Liu D, Zhou J, Ma D, Wang H. Zinc Finger Nucleases Targeting the Human Papillomavirus E7 Oncogene Induce E7 Disruption and a Transformed Phenotype in HPV16\/18-Positive Cervical Cancer Cells. Clin Cancer Res. 2014;20(24):6495\u2013503. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-0250.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"485_CR123","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01268-23","volume":"98","author":"K Nakajima","year":"2024","unstructured":"Nakajima K, Inagaki T, Espera JM, Izumiya Y. Kaposi\u2019s Sarcoma-Associated Herpesvirus (KSHV) LANA prevents KSHV episomes from degradation. J Virol. 2024;98(2):e0126823. https:\/\/doi.org\/10.1128\/jvi.01268-23.","journal-title":"J Virol"},{"key":"485_CR124","doi-asserted-by":"publisher","first-page":"11640207","DOI":"10.3389\/fonc.2021.640207","volume":"11","author":"AK Lo","year":"2021","unstructured":"Lo AK, Dawson CW, Lung HL, Wong KL, Young LS. The Role of EBV-Encoded Lmp1 in the Npc Tumor Microenvironment: From Function to Therapy. Front Oncol. 2021;11:11640207. https:\/\/doi.org\/10.3389\/fonc.2021.640207.","journal-title":"Front Oncol"},{"key":"485_CR125","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13027-019-0246-5","volume":"14","author":"H Huo","year":"2019","unstructured":"Huo H, Hu G. Crispr\/Cas9-Mediated Lmp1 Knockout Inhibits Epstein-Barr Virus Infection and Nasopharyngeal Carcinoma Cell Growth. Infect Agent Cancer. 2019;14:30. https:\/\/doi.org\/10.1186\/s13027-019-0246-5.","journal-title":"Infect Agent Cancer"},{"issue":"12","key":"485_CR126","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1136\/gutjnl-2023-331396","volume":"73","author":"AA Roca Suarez","year":"2024","unstructured":"Roca Suarez AA, Plissonnier ML, Grand X, Michelet M, Giraud G, Saez-Palma M, et al. Tlr8 Agonist Selgantolimod Regulates Kupffer Cell Differentiation Status and Impairs Hbv Entry into Hepatocytes Via an Il-6-Dependent Mechanism. Gut. 2024;73(12):2012\u201322. https:\/\/doi.org\/10.1136\/gutjnl-2023-331396.","journal-title":"Gut"},{"issue":"4","key":"485_CR127","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1002\/hep.31795","volume":"74","author":"EJ Gane","year":"2021","unstructured":"Gane EJ, Kim HJ, Visvanathan K, Kim YJ, Nguyen AH, Wallin JJ, et al. Safety, pharmacokinetics, and pharmacodynamics of the oral Tlr8 agonist Selgantolimod in chronic Hepatitis B. Hepatology. 2021;74(4):1737\u201349. https:\/\/doi.org\/10.1002\/hep.31795.","journal-title":"Hepatology"},{"issue":"1","key":"485_CR128","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/13510002.2019.1596431","volume":"24","author":"WA R\u00edos-Ocampo","year":"2019","unstructured":"R\u00edos-Ocampo WA, Daemen T, Buist-Homan M, Faber KN, Navas MC, Moshage H. Hepatitis C Virus core or Ns3\/4a protein expression preconditions hepatocytes against oxidative stress and endoplasmic reticulum stress. Redox Rep. 2019;24(1):17\u201326. https:\/\/doi.org\/10.1080\/13510002.2019.1596431.","journal-title":"Redox Rep"},{"issue":"2","key":"485_CR129","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3892\/mco.2019.1956","volume":"12","author":"K Imai","year":"2020","unstructured":"Imai K, Takai K, Hanai T, Suetsugu A, Shiraki M, Shimizu M. Sustained virological response by direct-acting antivirals reduces the recurrence risk of Hepatitis C-related Hepatocellular Carcinoma after curative treatment. Mol Clin Oncol. 2020;12(2):111\u20136. https:\/\/doi.org\/10.3892\/mco.2019.1956.","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"485_CR130","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.gendis.2023.02.050","volume":"11","author":"A Gajos-Michniewicz","year":"2024","unstructured":"Gajos-Michniewicz A, Czyz M. Wnt\/\u0392-Catenin signaling in Hepatocellular Carcinoma: the aberrant activation, pathogenic roles, and therapeutic opportunities. Genes Dis. 2024;11(2):727\u201346. https:\/\/doi.org\/10.1016\/j.gendis.2023.02.050.","journal-title":"Genes Dis"},{"key":"485_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2024.101423","volume":"67","author":"F Fiehn","year":"2024","unstructured":"Fiehn F, Beisel C, Binder M. Hepatitis C Virus and Hepatocellular Carcinoma: carcinogenesis in the era of direct-acting antivirals. Curr Opin Virol. 2024;67:101423. https:\/\/doi.org\/10.1016\/j.coviro.2024.101423.","journal-title":"Curr Opin Virol"},{"issue":"5","key":"485_CR132","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1158\/2643-3230.BCD-22-0139","volume":"4","author":"K Toyoda","year":"2023","unstructured":"Toyoda K, Yasunaga JI, Shichijo T, Arima Y, Tsujita K, Tanaka A, et al. HTLV-1 bZIP factor-induced reprogramming of lactate metabolism and epigenetic status promote leukemic cell expansion. Blood Cancer Discov. 2023;4(5):374\u201393. https:\/\/doi.org\/10.1158\/2643-3230.BCD-22-0139.","journal-title":"Blood Cancer Discov"},{"issue":"10","key":"485_CR133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009006","volume":"16","author":"MV Medina","year":"2020","unstructured":"Medina MV, Da A, Ma Q, Eroles P, Cavallin L, Chiozzini C, et al. KSHV G-protein coupled receptor VGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi\u2019s Sarcoma. PLoS Pathog. 2020;16(10):e1009006. https:\/\/doi.org\/10.1371\/journal.ppat.1009006.","journal-title":"PLoS Pathog"},{"issue":"21","key":"485_CR134","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00854-19","volume":"93","author":"ES Pringle","year":"2019","unstructured":"Pringle ES, Robinson CA, Mccormick C. Kaposi\u2019s Sarcoma-Associated Herpesvirus lytic replication interferes with Mtorc1 regulation of autophagy and viral protein synthesis. J Virol. 2019;93(21):e00854-19. https:\/\/doi.org\/10.1128\/jvi.00854-19.","journal-title":"J Virol"},{"issue":"5","key":"485_CR135","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/CCO.0b013e3281eb8ea7","volume":"19","author":"DP Dittmer","year":"2007","unstructured":"Dittmer DP, Krown SE. Targeted therapy for Kaposi\u2019s Sarcoma and Kaposi\u2019s Sarcoma-Associated Herpesvirus. Curr Opin Oncol. 2007;19(5):452\u20137. https:\/\/doi.org\/10.1097\/CCO.0b013e3281eb8ea7.","journal-title":"Curr Opin Oncol"},{"issue":"6","key":"485_CR136","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/17476348.2021.1916472","volume":"15","author":"SE Tanni","year":"2021","unstructured":"Tanni SE, Fabro AT, De Albuquerque A, Ferreira EVM, Verrastro CGY, Sawamura MVY, et al. Pulmonary fibrosis secondary to COVID-19: a narrative review. Expert Rev Respir Med. 2021;15(6):791\u2013803. https:\/\/doi.org\/10.1080\/17476348.2021.1916472.","journal-title":"Expert Rev Respir Med"},{"issue":"9","key":"485_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11091260","volume":"11","author":"A Temblador","year":"2019","unstructured":"Temblador A, Topalis D, Andrei G, Snoeck R. Crispr\/Cas9 editing of the Polyomavirus tumor antigens inhibits Merkel Cell Carcinoma growth in vitro. Cancers (Basel). 2019;11(9):1260. https:\/\/doi.org\/10.3390\/cancers11091260.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"485_CR138","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.det.2022.07.015","volume":"41","author":"DJ Lewis","year":"2023","unstructured":"Lewis DJ, Sobanko JF, Etzkorn JR, Shin TM, Giordano CN, McMurray SL, et al. Merkel Cell Carcinoma. Dermatol Clin. 2023;41(1):101\u201315. https:\/\/doi.org\/10.1016\/j.det.2022.07.015.","journal-title":"Dermatol Clin"},{"issue":"2","key":"485_CR139","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001672","volume":"8","author":"R Maniar","year":"2020","unstructured":"Maniar R, Anderson M, Taback B, Khan S, McDonnell D, Saqi A, et al. Case of Merkel cell carcinoma in a patient with pre-existing ILD. J Immunother Cancer. 2020;8(2):e001672. https:\/\/doi.org\/10.1136\/jitc-2020-001672.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"485_CR140","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02138","volume":"8","author":"S Bhatia","year":"2020","unstructured":"Bhatia S, Topalian SL, Sharfman W, Meyer T, Steven N, Lao CD, et al. Nivolumab With or Without Ipilimumab in Patients With Recurrent or Metastatic Merkel Cell Carcinoma: A Nonrandomized, Open-Label, International, Multicenter Phase I\/II Study. J Clin Oncol. 2020;8(2):e001672. https:\/\/doi.org\/10.1200\/JCO-24-02138.","journal-title":"J Clin Oncol"},{"issue":"4","key":"485_CR141","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1093\/cid\/ciaf204","volume":"81","author":"T Loosli","year":"2025","unstructured":"Loosli T, Bolton Moore C, Buzaalirwa L, Byakwaga H, \u00c7elika\u011f \u0130, Chimbetete C, et al. Drug resistance in people with viremia on Dolutegravir-based antiretroviral therapy in Sub-Saharan Africa: The DTG RESIST study. Clin Infect Dis. 2025;81(4):e128\u201331. https:\/\/doi.org\/10.1093\/cid\/ciaf204.","journal-title":"Clin Infect Dis"},{"issue":"15","key":"485_CR142","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1097\/QAD.0000000000004322","volume":"39","author":"M Veloso","year":"2025","unstructured":"Veloso M, Ribeiro M, Cabanas J, Gon\u00e7alves F, Fernandes S, Diogo I, et al. Emerging patterns in HIV integrase resistance. AIDS. 2025;39(15):2324\u20137. https:\/\/doi.org\/10.1097\/QAD.0000000000004322.","journal-title":"AIDS"},{"issue":"20","key":"485_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/cells14201629","volume":"14","author":"E Tsoneva","year":"2025","unstructured":"Tsoneva E, Yordanov A. HPV oncoproteins and mitochondrial reprogramming: The central role of ROMO1 in oxidative stress and metabolic shifts. Cells. 2025;14(20):1629. https:\/\/doi.org\/10.3390\/cells14201629.","journal-title":"Cells"},{"issue":"2","key":"485_CR144","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70197","volume":"97","author":"TM Yee","year":"2025","unstructured":"Yee TM, Wang LW. Metabolic reprogramming in Epstein-Barr Virus associated diseases. J Med Virol. 2025;97(2):e70197. https:\/\/doi.org\/10.1002\/jmv.70197.","journal-title":"J Med Virol"},{"issue":"5","key":"485_CR145","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/cancers11050647","volume":"11","author":"X Jiang","year":"2019","unstructured":"Jiang X, Tan HY, Teng S, Chan YT, Wang D, Wang N. The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma. Cancers. 2019;11(5):647. https:\/\/doi.org\/10.3390\/cancers11050647.","journal-title":"Cancers"},{"key":"485_CR146","doi-asserted-by":"publisher","DOI":"10.1177\/2040622320957143","volume":"11","author":"HM Wang","year":"2020","unstructured":"Wang HM, Lu YJ, He L, Gu NJ, Wang SY, Qiu XS, et al. Hpv16 E6\/E7 promote the translocation and glucose uptake of Glut1 by Pi3k\/Akt pathway via relieving Mir-451 inhibitory effect on Cab39 in lung cancer cells. Ther Adv Chronic Dis. 2020;11:2040622320957143. https:\/\/doi.org\/10.1177\/2040622320957143.","journal-title":"Ther Adv Chronic Dis"},{"issue":"1","key":"485_CR147","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45852-5","volume":"15","author":"Q Wan","year":"2024","unstructured":"Wan Q, Tavakoli L, Wang TY, Tucker AJ, Zhou R, Liu Q, et al. Hijacking of nucleotide biosynthesis and deamidation-mediated glycolysis by an oncogenic herpesvirus. Nat Commun. 2024;15(1):1442. https:\/\/doi.org\/10.1038\/s41467-024-45852-5.","journal-title":"Nat Commun"},{"issue":"11","key":"485_CR148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006020","volume":"12","author":"C Berrios","year":"2016","unstructured":"Berrios C, Padi M, Keibler MA, Park DE, Molla V, Cheng J, et al. Merkel Cell Polyomavirus Small T Antigen promotes pro-glycolytic metabolic perturbations required for transformation. PLoS Pathog. 2016;12(11):e1006020. https:\/\/doi.org\/10.1371\/journal.ppat.1006020.","journal-title":"PLoS Pathog"},{"key":"485_CR149","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.1068436","volume":"12","author":"JM Crater","year":"2022","unstructured":"Crater JM, Nixon DF, Furler O\u2019Brien RL. HIV-1 replication and latency are balanced by mTOR-driven cell metabolism. Front Cell Infect Microbiol. 2022;12:1068436. https:\/\/doi.org\/10.3389\/fcimb.2022.1068436.","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"485_CR150","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","volume":"187","author":"Z Zong","year":"2024","unstructured":"Zong Z, Xie F, Wang S, Wu X, Zhang Z, Yang B, et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 2024;187(10):2375-2392.e33. https:\/\/doi.org\/10.1016\/j.cell.2024.04.002.","journal-title":"Cell"},{"issue":"8036","key":"485_CR151","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41586-024-07992-y","volume":"634","author":"H Li","year":"2024","unstructured":"Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q, et al. AARS1 and AARS2 sense L-lactate to regulate cGAS as global lysine lactyltransferases. Nature. 2024;634(8036):1229\u201337. https:\/\/doi.org\/10.1038\/s41586-024-07992-y.","journal-title":"Nature"},{"issue":"9","key":"485_CR152","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","volume":"100","author":"T Mashima","year":"2009","unstructured":"Mashima T, Seimiya H, Tsuruo T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer. 2009;100(9):1369\u201372. https:\/\/doi.org\/10.1038\/sj.bjc.6605007.","journal-title":"Br J Cancer"},{"issue":"11","key":"485_CR153","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10111366","volume":"10","author":"T Datfar","year":"2021","unstructured":"Datfar T, Doulberis M, Papaefthymiou A, Hines IN, Manzini G. Viral hepatitis and hepatocellular carcinoma: state of the art. Pathogens. 2021;10(11):1366. https:\/\/doi.org\/10.3390\/pathogens10111366.","journal-title":"Pathogens"},{"issue":"8","key":"485_CR154","doi-asserted-by":"publisher","DOI":"10.3390\/biom9080351","volume":"9","author":"A Cruz-Gregorio","year":"2019","unstructured":"Cruz-Gregorio A, Aranda-Rivera AK, Aparicio-Trejo OE, Coronado-Mart\u00ednez I, Pedraza-Chaverri J, Lizano M. E6 oncoproteins from high-risk Human Papillomavirus induce mitochondrial metabolism in a Head and Neck Squamous Cell Carcinoma model. Biomolecules. 2019;9(8):351. https:\/\/doi.org\/10.3390\/biom9080351.","journal-title":"Biomolecules"},{"key":"485_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174397","volume":"909","author":"J Quan","year":"2021","unstructured":"Quan J, Bode AM, Luo X. ACSL family: the regulatory mechanisms and therapeutic implications in cancer. Eur J Pharmacol. 2021;909:174397. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174397.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"485_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112286","volume":"42","author":"X Tan","year":"2023","unstructured":"Tan X, Cai K, Li J, Yuan Z, Chen R, Xiao H, et al. Coronavirus subverts ER-phagy by hijacking FAM134B and ATL3 into p62 condensates to facilitate viral replication. Cell Rep. 2023;42(4):112286. https:\/\/doi.org\/10.1016\/j.celrep.2023.112286.","journal-title":"Cell Rep"},{"issue":"9","key":"485_CR157","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097734","volume":"24","author":"T Ivanova","year":"2023","unstructured":"Ivanova T, Mariienko Y, Mehterov N, Kazakova M, Sbirkov Y, Todorova K, et al. Autophagy and SARS-CoV-2-old players in new games. Int J Mol Sci. 2023;24(9):7734. https:\/\/doi.org\/10.3390\/ijms24097734.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"485_CR158","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2013.07.030","volume":"345","author":"SA Read","year":"2014","unstructured":"Read SA, Douglas MW. Virus induced inflammation and cancer development. Cancer Lett. 2014;345(2):174\u201381. https:\/\/doi.org\/10.1016\/j.canlet.2013.07.030.","journal-title":"Cancer Lett"},{"issue":"17","key":"485_CR159","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.3390\/cancers13174387","volume":"13","author":"M Borgia","year":"2021","unstructured":"Borgia M, Dal Bo M, Toffoli G. Role of Virus-Related Chronic Inflammation and Mechanisms of Cancer Immune-Suppression in Pathogenesis and Progression of Hepatocellular Carcinoma. Cancers (Basel). 2021;13(17):4387. https:\/\/doi.org\/10.3390\/cancers13174387.","journal-title":"Cancers (Basel)"},{"key":"485_CR160","doi-asserted-by":"publisher","unstructured":"McKee KS, Carter KA, Bassis C, Young VB, Reed B, Harper DM, et al. The vaginal microbiota, high-risk human papillomavirus infection, and cervical cytology: results from a population-based study. Gynecol Pelvic Med. 2020;3:18. https:\/\/doi.org\/10.21037\/gpm-20-10.","DOI":"10.21037\/gpm-20-10"},{"issue":"1","key":"485_CR161","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.24675","volume":"55","author":"C Wang","year":"2012","unstructured":"Wang C, Yang W, Yan HX, Luo T, Zhang J, Tang L, et al. Hepatitis B virus X (HBx) induces tumorigenicity of hepatic progenitor cells in 3,5-diethoxycarbonyl-1,4-dihydrocollidine-treated HBx transgenic mice. Hepatology. 2012;55(1):108\u201320. https:\/\/doi.org\/10.1002\/hep.24675.","journal-title":"Hepatology"},{"key":"485_CR162","doi-asserted-by":"publisher","unstructured":"Howe AYM, Rodrigo C, Cunningham EB, Douglas MW, Dietz J, Grebely J, et al. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals. JHEP Rep. 2022; 10.1Soliman SHA, Orlacchio A, Verginelli F. Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis. Microorganisms. 2021;9(6):1179. https:\/\/doi.org\/10.3390\/microorganisms9061179.","DOI":"10.3390\/microorganisms9061179"},{"key":"485_CR163","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01236","volume":"9","author":"E Guven-Maiorov","year":"2019","unstructured":"Guven-Maiorov E, Tsai CJ, Nussinov R. Oncoviruses can drive cancer by rewiring signaling pathways through interface mimicry. Front Oncol. 2019;9:1236. https:\/\/doi.org\/10.3389\/fonc.2019.01236.","journal-title":"Front Oncol"},{"key":"485_CR164","doi-asserted-by":"publisher","unstructured":"Yang JJ, Sang W, Xu KL. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2019;40(3):261\u2013264. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2019.03.021.","DOI":"10.3760\/cma.j.issn.0253-2727.2019.03.021"},{"issue":"11","key":"485_CR165","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70718","volume":"97","author":"Z Qin","year":"2025","unstructured":"Qin Z, Dai L. Recent advances in development of Kaposi\u2019s Sarcoma-Associated Herpesvirus-Latency-Associated Nuclear Antigen targeted therapies. J Med Virol. 2025;97(11):e70718. https:\/\/doi.org\/10.1002\/jmv.70718.","journal-title":"J Med Virol"},{"issue":"7","key":"485_CR166","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S1470-2045(24)00189-X","volume":"25","author":"F Jin","year":"2024","unstructured":"Jin F, Vajdic CM, Poynten IM, McGee-Avila JK, Castle PE, Grulich AE. Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis. Lancet Oncol. 2024;25(7):933\u201344. https:\/\/doi.org\/10.1016\/S1470-2045(24)00189-X.","journal-title":"Lancet Oncol"},{"issue":"3","key":"485_CR167","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"485_CR168","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1272546","volume":"14","author":"Q Cao","year":"2023","unstructured":"Cao Q, Wang Q, Wu X, Zhang Q, Huang J, Chen Y, et al. A literature review: mechanisms of antitumor pharmacological action of leonurine alkaloid. Front Pharmacol. 2023;14:1272546. https:\/\/doi.org\/10.3389\/fphar.2023.1272546.","journal-title":"Front Pharmacol"},{"issue":"1","key":"485_CR169","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02448-x","volume":"24","author":"XY Wei","year":"2025","unstructured":"Wei XY, Feng HJ, Zhu YY, Guo SJ, Wang H, Li M, et al. The immune microenvironment of pathogen-associated cancers and current clinical therapeutics. Mol Cancer. 2025;24(1):232. https:\/\/doi.org\/10.1186\/s12943-025-02448-x.","journal-title":"Mol Cancer"},{"issue":"2","key":"485_CR170","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5858\/arpa.2012-0101-RS","volume":"137","author":"O Radu","year":"2013","unstructured":"Radu O, Pantanowitz L. Kaposi sarcoma. Arch Pathol Lab Med. 2013;137(2):289\u201394. https:\/\/doi.org\/10.5858\/arpa.2012-0101-RS.","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"485_CR171","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/s12276-024-01335-7","volume":"56","author":"A Lyu","year":"2024","unstructured":"Lyu A, Nam SH, Humphrey RS, Horton TM, Ehrlich LIR. Cells and signals of the leukemic microenvironment that support progression of T-cell acute lymphoblastic leukemia (T-ALL). Exp Mol Med. 2024;56(11):2337\u201347. https:\/\/doi.org\/10.1038\/s12276-024-01335-7.","journal-title":"Exp Mol Med"},{"issue":"8","key":"485_CR172","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70564","volume":"97","author":"Q Wang","year":"2025","unstructured":"Wang Q, Zhang C, Liu S, Li W, Wei W, Aziz AUR, et al. Role of NTRK fusion genes in the tumor immune microenvironment of HPV (+\/-) cervical cancer. J Med Virol. 2025;97(8):e70564. https:\/\/doi.org\/10.1002\/jmv.70564.","journal-title":"J Med Virol"},{"issue":"29","key":"485_CR173","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203040","volume":"9","author":"Z Ou","year":"2022","unstructured":"Ou Z, Lin S, Qiu J, Ding W, Ren P, Chen D, et al. Single-nucleus RNA sequencing and spatial transcriptomics reveal the immunological microenvironment of cervical squamous cell carcinoma. Adv Sci. 2022;9(29):e2203040. https:\/\/doi.org\/10.1002\/advs.202203040.","journal-title":"Adv Sci"},{"key":"485_CR174","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.567116","volume":"10","author":"G Herbein","year":"2020","unstructured":"Herbein G, Nehme Z. Polyploid giant cancer cells, a hallmark of oncoviruses and a new therapeutic challenge. Front Oncol. 2020;10:567116. https:\/\/doi.org\/10.3389\/fonc.2020.567116.","journal-title":"Front Oncol"},{"issue":"5","key":"485_CR175","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1038\/s41418-019-0435-1","volume":"27","author":"L Fitzsimmons","year":"2020","unstructured":"Fitzsimmons L, Cartlidge R, Chang C, Sejic N, Galbraith LCA, Suraweera CD, et al. EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins. Cell Death Differ. 2020;27(5):1554\u201368. https:\/\/doi.org\/10.1038\/s41418-019-0435-1.","journal-title":"Cell Death Differ"},{"issue":"7","key":"485_CR176","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1111\/cas.13634","volume":"109","author":"H Li","year":"2018","unstructured":"Li H, Hu J, Luo X, Bode AM, Dong Z, Cao Y. Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies. Cancer Sci. 2018;109(7):2101\u20138. https:\/\/doi.org\/10.1111\/cas.13634.","journal-title":"Cancer Sci"},{"issue":"3","key":"485_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115432","volume":"44","author":"EJ Kay","year":"2025","unstructured":"Kay EJ, Zanivan S. The tumor microenvironment is an ecosystem sustained by metabolic interactions. Cell Rep. 2025;44(3):115432. https:\/\/doi.org\/10.1016\/j.celrep.2025.115432.","journal-title":"Cell Rep"},{"issue":"1","key":"485_CR178","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059.","journal-title":"Cancer Discov"},{"key":"485_CR179","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02309","volume":"10","author":"I Magalhaes","year":"2019","unstructured":"Magalhaes I, Yogev O, Mattsson J, Schurich A. The metabolic profile of tumor and virally infected cells shapes their microenvironment counteracting T cell immunity. Front Immunol. 2019;10:2309. https:\/\/doi.org\/10.3389\/fimmu.2019.02309.","journal-title":"Front Immunol"},{"issue":"3","key":"485_CR180","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano T. Il-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127\u201348. https:\/\/doi.org\/10.1093\/intimm\/dxaa078.","journal-title":"Int Immunol"},{"issue":"8","key":"485_CR181","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun SC. Nf-\u03bab in inflammation and cancer. Cell Mol Immunol. 2025;22(8):811\u201339. https:\/\/doi.org\/10.1038\/s41423-025-01310-w.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"485_CR182","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/mco2.104","volume":"2","author":"T Zhang","year":"2021","unstructured":"Zhang T, Ma C, Zhang Z, Zhang H, Hu H. NF-\u039aB signaling in inflammation and cancer. MedComm (2020). 2021;2(4):618\u201353. https:\/\/doi.org\/10.1002\/mco2.104.","journal-title":"MedComm (2020)"},{"issue":"7","key":"485_CR183","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1158\/2159-8290.Cd-22-1220","volume":"13","author":"V Klapp","year":"2023","unstructured":"Klapp V, \u00c1lvarez-Abril B, Leuzzi G, Kroemer G, Ciccia A, Galluzzi L. The DNA damage response and inflammation in cancer. Cancer Discov. 2023;13(7):1521\u201345. https:\/\/doi.org\/10.1158\/2159-8290.Cd-22-1220.","journal-title":"Cancer Discov"},{"issue":"1","key":"485_CR184","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01688-0","volume":"18","author":"H Jia","year":"2025","unstructured":"Jia H, Chen X, Zhang L, Chen M. Cancer associated fibroblasts in cancer development and therapy. J Hematol Oncol. 2025;18(1):36. https:\/\/doi.org\/10.1186\/s13045-025-01688-0.","journal-title":"J Hematol Oncol"},{"issue":"7","key":"485_CR185","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41388-021-02145-1","volume":"41","author":"JJ Roetman","year":"2022","unstructured":"Roetman JJ, Apostolova MKI, Philip M. Viral and cellular oncogenes promote immune evasion. Oncogene. 2022;41(7):921\u20139. https:\/\/doi.org\/10.1038\/s41388-021-02145-1.","journal-title":"Oncogene"},{"issue":"1","key":"485_CR186","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","volume":"42","author":"A Baessler","year":"2024","unstructured":"Baessler A, Vignali DAA. T cell exhaustion. Annu Rev Immunol. 2024;42(1):179\u2013206. https:\/\/doi.org\/10.1146\/annurev-immunol-090222-110914. (Epub 2024 Jun 14.).","journal-title":"Annu Rev Immunol"},{"key":"485_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1149622","volume":"14","author":"JT Ding","year":"2023","unstructured":"Ding JT, Yang KP, Zhou HN, Huang YF, Li H, Zong Z. Landscapes and mechanisms of Cd8(+) T cell exhaustion in gastrointestinal cancer. Front Immunol. 2023;14:1149622. https:\/\/doi.org\/10.3389\/fimmu.2023.1149622.","journal-title":"Front Immunol"},{"issue":"2","key":"485_CR188","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.immuni.2024.01.010","volume":"57","author":"N Joller","year":"2024","unstructured":"Joller N, Anderson AC, Kuchroo VK. Lag-3, Tim-3, and Tigit: distinct functions in immune regulation. Immunity. 2024;57(2):206\u201322. https:\/\/doi.org\/10.1016\/j.immuni.2024.01.010.","journal-title":"Immunity"},{"issue":"14","key":"485_CR189","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143552","volume":"14","author":"J Li","year":"2022","unstructured":"Li J, Zhang Y, Luo B. Effects of exosomal viral components on the tumor microenvironment. Cancers (Basel). 2022;14(14):3552. https:\/\/doi.org\/10.3390\/cancers14143552.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"485_CR190","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-022-00471-x","volume":"17","author":"S Mahmoudvand","year":"2022","unstructured":"Mahmoudvand S, Shokri S, Nakhaie M, Jalilian FA, Mehri-Ghahfarrokhi A, Yarani R, et al. Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses. Infect Agent Cancer. 2022;17(1):58. https:\/\/doi.org\/10.1186\/s13027-022-00471-x.","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"485_CR191","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29685","volume":"96","author":"I Lo Cigno","year":"2024","unstructured":"Lo Cigno I, Calati F, Girone C, Catozzo M, Gariglio M. High-risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: uncovering mechanisms of immune evasion and therapeutic prospects. J Med Virol. 2024;96(6):e29685. https:\/\/doi.org\/10.1002\/jmv.29685.","journal-title":"J Med Virol"},{"issue":"1","key":"485_CR192","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14138-4","volume":"25","author":"K Li","year":"2025","unstructured":"Li K, Huang F, Zhang T, Yang F, Duan W, Chen S, et al. HPV integration status conversion and Cin2\u2009+\u2009cancer risk stratification based on HPV integration levels among HPV integration-positive women: a 1-year follow-up study. BMC Cancer. 2025;25(1):885. https:\/\/doi.org\/10.1186\/s12885-025-14138-4.","journal-title":"BMC Cancer"},{"key":"485_CR193","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ebiom.2019.04.028","volume":"44","author":"ZE Ilhan","year":"2019","unstructured":"Ilhan ZE, \u0141aniewski P, Thomas N, Roe DJ, Chase DM, Herbst-Kralovetz MM. Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling. EBioMedicine. 2019;44:675\u201390. https:\/\/doi.org\/10.1016\/j.ebiom.2019.04.028.","journal-title":"EBioMedicine"},{"issue":"1","key":"485_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46340-4","volume":"13","author":"B Wolf","year":"2023","unstructured":"Wolf B, Weydandt L, Dornh\u00f6fer N, Hiller GGR, H\u00f6hn AK, Nel I, et al. Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype. Sci Rep. 2023;13(1):18946. https:\/\/doi.org\/10.1038\/s41598-023-46340-4.","journal-title":"Sci Rep"},{"issue":"1","key":"485_CR195","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06896-3","volume":"23","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Liu M, An Y, Gao C, Wang T, Zhang Z, et al. Targeting immune microenvironment in cervical cancer: current research and advances. J Transl Med. 2025;23(1):888. https:\/\/doi.org\/10.1186\/s12967-025-06896-3.","journal-title":"J Transl Med"},{"issue":"1","key":"485_CR196","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02965-w","volume":"21","author":"SJ Bowden","year":"2023","unstructured":"Bowden SJ, Doulgeraki T, Bouras E, Markozannes G, Athanasiou A, Grout-Smith H, et al. Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies. BMC Med. 2023;21(1):274. https:\/\/doi.org\/10.1186\/s12916-023-02965-w.","journal-title":"BMC Med"},{"issue":"1","key":"485_CR197","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-020-01745-1","volume":"39","author":"JJ Qiu","year":"2020","unstructured":"Qiu JJ, Sun SG, Tang XY, Lin YY, Hua KQ. Extracellular vesicular Wnt7b mediates HPV E6-induced cervical cancer angiogenesis by activating the \u0392-catenin signaling pathway. J Exp Clin Cancer Res. 2020;39(1):260. https:\/\/doi.org\/10.1186\/s13046-020-01745-1.","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"485_CR198","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204951","volume":"10","author":"J Qiu","year":"2023","unstructured":"Qiu J, Qu X, Wang Y, Guo C, Lv B, Jiang Q, et al. Single-cell landscape highlights heterogenous microenvironment, novel immune reaction patterns, potential biomarkers and unique therapeutic strategies of cervical squamous carcinoma, human papillomavirus-associated (HPVA) and non-HPVA adenocarcinoma. Adv Sci (Weinh). 2023;10(10):e2204951. https:\/\/doi.org\/10.1002\/advs.202204951.","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"485_CR199","doi-asserted-by":"publisher","DOI":"10.3390\/genes15091127","volume":"15","author":"J Myrda","year":"2024","unstructured":"Myrda J, Bremm F, Schaft N, D\u00f6rrie J. The role of the large T Antigen in the molecular pathogenesis of Merkel Cell Carcinoma. Genes (Basel). 2024;15(9):1127. https:\/\/doi.org\/10.3390\/genes15091127.","journal-title":"Genes (Basel)"},{"issue":"5","key":"485_CR200","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2580","volume":"34","author":"T Chokwassanasakulkit","year":"2024","unstructured":"Chokwassanasakulkit T, Mcmillan NAJ. Merkel Cell Polyomavirus-pathophysiology and treatment in the era of gene-targeted therapies. Rev Med Virol. 2024;34(5):e2580. https:\/\/doi.org\/10.1002\/rmv.2580.","journal-title":"Rev Med Virol"},{"issue":"11","key":"485_CR201","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1158\/1541-7786.Mcr-20-0587","volume":"18","author":"J Zhao","year":"2020","unstructured":"Zhao J, Jia Y, Shen S, Kim J, Wang X, Lee E, et al. Merkel Cell Polyomavirus small T Antigen activates noncanonical Nf-\u03bab signaling to promote tumorigenesis. Mol Cancer Res. 2020;18(11):1623\u201337. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-20-0587.","journal-title":"Mol Cancer Res"},{"issue":"10","key":"485_CR202","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2017.1338237","volume":"6","author":"D Schadendorf","year":"2017","unstructured":"Schadendorf D, Nghiem P, Bhatia S, Hauschild A, Saiag P, Mahnke L, et al. Immune evasion mechanisms and immune checkpoint inhibition in advanced Merkel Cell Carcinoma. Oncoimmunology. 2017;6(10):e1338237. https:\/\/doi.org\/10.1080\/2162402x.2017.1338237.","journal-title":"Oncoimmunology"},{"issue":"7","key":"485_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101101","volume":"4","author":"BK Das","year":"2023","unstructured":"Das BK, Kannan A, Velasco GJ, Kunika MD, Lambrecht N, Nguyen Q, et al. Single-cell dissection of Merkel Cell Carcinoma heterogeneity unveils transcriptomic plasticity and therapeutic vulnerabilities. Cell Rep Med. 2023;4(7):101101. https:\/\/doi.org\/10.1016\/j.xcrm.2023.101101.","journal-title":"Cell Rep Med"},{"issue":"6","key":"485_CR204","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1158\/1078-0432.Ccr-23-1957","volume":"30","author":"S Tabachnick-Cherny","year":"2024","unstructured":"Tabachnick-Cherny S, Pulliam T, Rodriguez HJ, Fan X, Hippe DS, Jones DC, et al. Characterization of immunosuppressive myeloid cells in Merkel Cell Carcinoma: correlation with resistance to PD-1 pathway blockade. Clin Cancer Res. 2024;30(6):1189\u201399. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-1957.","journal-title":"Clin Cancer Res"},{"key":"485_CR205","doi-asserted-by":"publisher","DOI":"10.20517\/2394-5079.2020.83","volume":"7","author":"O Andrisani","year":"2021","unstructured":"Andrisani O. Epigenetic mechanisms in Hepatitis B Virus-Associated Hepatocellular Carcinoma. Hepatoma Res. 2021;7:12. https:\/\/doi.org\/10.20517\/2394-5079.2020.83.","journal-title":"Hepatoma Res"},{"key":"485_CR206","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12879-025-10852-3","volume":"8","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Han Q, Zhao H, Zhang J. The mechanisms of HBV-induced Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021;8:435\u201350. https:\/\/doi.org\/10.1186\/s12879-025-10852-3.","journal-title":"J Hepatocell Carcinoma"},{"issue":"9","key":"485_CR207","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2025.102135","volume":"29","author":"M Akabane","year":"2025","unstructured":"Akabane M, Kawashima J, Woldesenbet S, Lee GR, Cauchy F, Aucejo F, et al. Distinct patterns of late recurrence in long-term Hepatocellular Carcinoma survivors. J Gastrointest Surg. 2025;29(9):102135. https:\/\/doi.org\/10.1016\/j.gassur.2025.102135.","journal-title":"J Gastrointest Surg"},{"issue":"9","key":"485_CR208","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3748\/wjg.v28.i9.881","volume":"28","author":"HJ Zhao","year":"2022","unstructured":"Zhao HJ, Hu YF, Han QJ, Zhang J. Innate and adaptive immune escape mechanisms of Hepatitis B Virus. World J Gastroenterol. 2022;28(9):881\u201396. https:\/\/doi.org\/10.3748\/wjg.v28.i9.881.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"485_CR209","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00281-021-00864-x","volume":"43","author":"M Dandri","year":"2021","unstructured":"Dandri M, Bertoletti A, L\u00fctgehetmann M. Innate immunity in Hepatitis B and D Virus infection: consequences for viral persistence, inflammation, and T Cell recognition. Semin Immunopathol. 2021;43(4):535\u201348. https:\/\/doi.org\/10.1007\/s00281-021-00864-x.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"485_CR210","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jnci\/djad172","volume":"116","author":"JK Mcgee-Avila","year":"2024","unstructured":"Mcgee-Avila JK, Argirion I, Engels EA, O\u2019brien TR, Horner MJ, Qiao B, et al. Risk of Hepatocellular Carcinoma in people with HIV in the United States, 2001-2019. J Natl Cancer Inst. 2024;116(1):61\u20138. https:\/\/doi.org\/10.1093\/jnci\/djad172.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"485_CR211","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a036988","volume":"11","author":"J Schwerk","year":"2021","unstructured":"Schwerk J, Negash A, Savan R, Gale M Jr. Innate immunity in Hepatitis C Virus infection. Cold Spring Harb Perspect Med. 2021;11(2):a036988. https:\/\/doi.org\/10.1101\/cshperspect.a036988.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"11","key":"485_CR212","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119671","volume":"24","author":"Q Pei","year":"2023","unstructured":"Pei Q, Yi Q, Tang L. Liver fibrosis resolution: from molecular mechanisms to therapeutic opportunities. Int J Mol Sci. 2023;24(11):9671. https:\/\/doi.org\/10.3390\/ijms24119671.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"485_CR213","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32283-3","volume":"13","author":"Y Lu","year":"2022","unstructured":"Lu Y, Yang A, Quan C, Pan Y, Zhang H, Li Y, et al. A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nat Commun. 2022;13(1):4594. https:\/\/doi.org\/10.1038\/s41467-022-32283-3.","journal-title":"Nat Commun"},{"key":"485_CR214","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coviro.2020.10.002","volume":"46","author":"JD Stuart","year":"2021","unstructured":"Stuart JD, Salinas E, Grakoui A. Immune system control of Hepatitis C Virus infection. Curr Opin Virol. 2021;46:36\u201344. https:\/\/doi.org\/10.1016\/j.coviro.2020.10.002.","journal-title":"Curr Opin Virol"},{"issue":"1","key":"485_CR215","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-0038-1676806","volume":"39","author":"YM Yang","year":"2019","unstructured":"Yang YM, Kim SY, Seki E. Inflammation and liver cancer: molecular mechanisms and therapeutic targets. Semin Liver Dis. 2019;39(1):26\u201342. https:\/\/doi.org\/10.1055\/s-0038-1676806.","journal-title":"Semin Liver Dis"},{"issue":"10","key":"485_CR216","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27103159","volume":"27","author":"N Sadasivam","year":"2022","unstructured":"Sadasivam N, Kim YJ, Radhakrishnan K, Kim DK. Oxidative stress, genomic integrity, and liver diseases. Molecules. 2022;27(10):3159. https:\/\/doi.org\/10.3390\/molecules27103159.","journal-title":"Molecules"},{"issue":"3","key":"485_CR217","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030790","volume":"9","author":"AR Ferreira","year":"2020","unstructured":"Ferreira AR, Ramos B, Nunes A, Ribeiro D. Hepatitis C Virus: evading the intracellular innate immunity. J Clin Med. 2020;9(3):790. https:\/\/doi.org\/10.3390\/jcm9030790.","journal-title":"J Clin Med"},{"key":"485_CR218","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.832206","volume":"13","author":"M Zielenkiewicz","year":"2022","unstructured":"Zielenkiewicz M, Radkowski M, Caraballo Cort\u00e9s K. Cd8(+) T-cell exhaustion phenotype in chronic Hepatitis C Virus infection is associated with epitope sequence variation. Front Immunol. 2022;13:832206. https:\/\/doi.org\/10.3389\/fimmu.2022.832206.","journal-title":"Front Immunol"},{"key":"485_CR219","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1297994","volume":"15","author":"JM Silva","year":"2024","unstructured":"Silva JM, Alves CEC, Pontes GS. Epstein-Barr virus: the mastermind of immune chaos. Front Immunol. 2024;15:1297994. https:\/\/doi.org\/10.3389\/fimmu.2024.1297994.","journal-title":"Front Immunol"},{"issue":"1","key":"485_CR220","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02456-5","volume":"41","author":"PJ Lee","year":"2022","unstructured":"Lee PJ, Sui YH, Liu TT, Tsang NM, Huang CH, Lin TY, et al. Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of Yap1\/Fap\u03b1 signaling in fibroblasts. J Exp Clin Cancer Res. 2022;41(1):254. https:\/\/doi.org\/10.1186\/s13046-022-02456-5.","journal-title":"J Exp Clin Cancer Res"},{"key":"485_CR221","doi-asserted-by":"publisher","first-page":"1289313","DOI":"10.3389\/fimmu.2023.1289313","volume":"14","author":"DG Sausen","year":"2023","unstructured":"Sausen DG, Poirier MC, Spiers LM, Smith EN. Mechanisms of T Cell Evasion by Epstein-Barr Virus and Implications for Tumor Survival. Front Immunol. 2023;14:1289313. https:\/\/doi.org\/10.3389\/fimmu.2023.1289313.","journal-title":"Front Immunol"},{"key":"485_CR222","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2023.10.004","volume":"265","author":"D Lenoci","year":"2024","unstructured":"Lenoci D, Resteghini C, Serafini MS, Pistore F, Canevari S, Ma B, et al. Tumor Molecular Landscape of Epstein-Barr Virus (EBV) Related Nasopharyngeal Carcinoma in EBV-Endemic and Non-Endemic Areas: Implications for Improving Treatment Modalities. Transl Res. 2024;265:1\u201316. https:\/\/doi.org\/10.1016\/j.trsl.2023.10.004.","journal-title":"Transl Res"},{"key":"485_CR223","doi-asserted-by":"publisher","first-page":"1059133","DOI":"10.3389\/fimmu.2022.1059133","volume":"13","author":"S Chakravorty","year":"2022","unstructured":"Chakravorty S, Afzali B, Kazemian M. EBV-Associated Diseases: Current Therapeutics and Emerging Technologies. Front Immunol. 2022;13:1059133. https:\/\/doi.org\/10.3389\/fimmu.2022.1059133.","journal-title":"Front Immunol"},{"issue":"11","key":"485_CR224","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41422-020-00402-8","volume":"30","author":"S Jin","year":"2020","unstructured":"Jin S, Li R, Chen MY, Yu C, Tang LQ, Liu YM, et al. Single-Cell Transcriptomic Analysis Defines the Interplay between Tumor Cells, Viral Infection, and the Microenvironment in Nasopharyngeal Carcinoma. Cell Res. 2020;30(11):950\u201365. https:\/\/doi.org\/10.1038\/s41422-020-00402-8.","journal-title":"Cell Res"},{"issue":"6","key":"485_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102012","volume":"298","author":"C Bagn\u00e9ris","year":"2022","unstructured":"Bagn\u00e9ris C, Senthil Kumar SL, Baratchian M, Britt HM, Assafa TE, Thalassinos K, et al. Mechanistic Insights into the Activation of the Ikk Kinase Complex by the Kaposi\u2019s Sarcoma Herpes Virus Oncoprotein Vflip. J Biol Chem. 2022;298(6):102012. https:\/\/doi.org\/10.1016\/j.jbc.2022.102012.","journal-title":"J Biol Chem"},{"issue":"12","key":"485_CR226","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.3390\/v16121900","volume":"16","author":"S Komaki","year":"2024","unstructured":"Komaki S, Inagaki T, Kumar A, Izumiya Y. The Role of Vil-6 in KSHV-Mediated Immune Evasion and Tumorigenesis. Viruses. 2024;16(12):1900. https:\/\/doi.org\/10.3390\/v16121900.","journal-title":"Viruses"},{"key":"485_CR227","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.3389\/fimmu.2019.03084","volume":"10","author":"G Broussard","year":"2019","unstructured":"Broussard G, Damania BKSHV. Immune Modulation and Immunotherapy Front Immunol. 2019;10:3084. https:\/\/doi.org\/10.3389\/fimmu.2019.03084.","journal-title":"Immune Modulation and Immunotherapy Front Immunol"},{"issue":"5","key":"485_CR228","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.chom.2024.03.012","volume":"32","author":"SH Sin","year":"2024","unstructured":"Sin SH, Eason AB, Kim Y, Schneider JW, Damania B, Dittmer DP. The Complete Kaposi Sarcoma-Associated Herpesvirus Genome Induces Early-Onset, Metastatic Angiosarcoma in Transgenic Mice. Cell Host Microbe. 2024;32(5):755-767.e4. https:\/\/doi.org\/10.1016\/j.chom.2024.03.012.","journal-title":"Cell Host Microbe"},{"issue":"17","key":"485_CR229","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1080\/15384101.2017.1356509","volume":"16","author":"N Bhaskaran","year":"2017","unstructured":"Bhaskaran N, Ghosh SK, Yu X, Qin S, Weinberg A, Pandiyan P, et al. Kaposi\u2019s Sarcoma-Associated Herpesvirus Infection Promotes Differentiation and Polarization of Monocytes into Tumor-Associated Macrophages. Cell Cycle. 2017;16(17):1611\u201321. https:\/\/doi.org\/10.1080\/15384101.2017.1356509.","journal-title":"Cell Cycle"},{"issue":"7","key":"485_CR230","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/gutjnl-2019-319200","volume":"69","author":"C Heichler","year":"2020","unstructured":"Heichler C, Scheibe K, Schmied A, Geppert CI, Schmid B, Wirtz S, et al. STAT3 Activation through IL-6\/IL-11 in Cancer-Associated Fibroblasts Promotes Colorectal Tumour Development and Correlates with Poor Prognosis. Gut. 2020;69(7):1269\u201382. https:\/\/doi.org\/10.1136\/gutjnl-2019-319200.","journal-title":"Gut"},{"issue":"5","key":"485_CR231","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01384-19","volume":"94","author":"R Rivera-Soto","year":"2020","unstructured":"Rivera-Soto R, Dissinger NJ, Damania B. Kaposi\u2019s sarcoma-associated herpesvirus viral interleukin-6 signaling upregulates integrin \u03923 levels and is dependent on Stat3. J Virol. 2020;94(5):e01384-19. https:\/\/doi.org\/10.1128\/jvi.01384-19.","journal-title":"J Virol"},{"issue":"5","key":"485_CR232","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12051242","volume":"12","author":"G Rusu-Zota","year":"2022","unstructured":"Rusu-Zota G, Manole OM, Gale\u0219 C, Porumb-Andrese E, Obad\u0103 O, Mocanu CV. Kaposi sarcoma, a trifecta of pathogenic mechanisms. Diagnostics (Basel). 2022;12(5):1242. https:\/\/doi.org\/10.3390\/diagnostics12051242.","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"485_CR233","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41564-025-02006-7","volume":"10","author":"K Sugata","year":"2025","unstructured":"Sugata K, Rahman A, Niimura K, Monde K, Ueno T, Rajib SA, et al. Intragenic viral silencer element regulates HTLV-1 latency via Runx complex recruitment. Nat Microbiol. 2025;10(6):1447\u201362. https:\/\/doi.org\/10.1038\/s41564-025-02006-7.","journal-title":"Nat Microbiol"},{"issue":"3","key":"485_CR234","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030546","volume":"16","author":"A Omar","year":"2024","unstructured":"Omar A, Marques N, Crawford N. Cancer and HIV: the molecular mechanisms of the deadly duo. Cancers (Basel). 2024;16(3):546. https:\/\/doi.org\/10.3390\/cancers16030546.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"485_CR235","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/QAD.0b013e32835f6b0c","volume":"27","author":"\u00c1H Borges","year":"2013","unstructured":"Borges \u00c1H, Silverberg MJ, Wentworth D, Grulich AE, F\u00e4tkenheuer G, Mitsuyasu R, et al. Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers. AIDS. 2013;27(9):1433\u201341. https:\/\/doi.org\/10.1097\/QAD.0b013e32835f6b0c.","journal-title":"AIDS"},{"issue":"11","key":"485_CR236","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.7150\/ijbs.38146","volume":"15","author":"H Li","year":"2019","unstructured":"Li H, Chi X, Li R, Ouyang J, Chen Y. HIV-1-infected cell-derived exosomes promote the growth and progression of cervical cancer. Int J Biol Sci. 2019;15(11):2438\u201347. https:\/\/doi.org\/10.7150\/ijbs.38146.","journal-title":"Int J Biol Sci"},{"issue":"14","key":"485_CR237","doi-asserted-by":"publisher","DOI":"10.1172\/jci177310","volume":"135","author":"SS Desai","year":"2025","unstructured":"Desai SS, Salahuddin S, Yusuf R, Ranjan K, Gu J, Osmani L, et al. The tumor microenvironment of non-small cell lung cancer impairs immune cell function in people with HIV. J Clin Invest. 2025;135(14):e177310. https:\/\/doi.org\/10.1172\/jci177310.","journal-title":"J Clin Invest"},{"issue":"1","key":"485_CR238","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1080\/22221751.2020.1826361","volume":"9","author":"S Wang","year":"2020","unstructured":"Wang S, Zhang Q, Hui H, Agrawal K, Karris MAY, Rana TM. An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics. Emerg Microbes Infect. 2020;9(1):2333\u201347. https:\/\/doi.org\/10.1080\/22221751.2020.1826361.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"485_CR239","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1545","volume":"14","author":"X Di","year":"2024","unstructured":"Di X, Chen J, Li Y, Wang M, Wei J, Li T, et al. Crosstalk between fibroblasts and immunocytes in fibrosis: from molecular mechanisms to clinical trials. Clin Transl Med. 2024;14(1):e1545. https:\/\/doi.org\/10.1002\/ctm2.1545.","journal-title":"Clin Transl Med"},{"issue":"1","key":"485_CR240","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-022-00856-w","volume":"12","author":"X Zhao","year":"2022","unstructured":"Zhao X, Chen J, Sun H, Zhang Y, Zou D. New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction. Cell Biosci. 2022;12(1):117. https:\/\/doi.org\/10.1186\/s13578-022-00856-w.","journal-title":"Cell Biosci"},{"issue":"11","key":"485_CR241","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70025","volume":"96","author":"X Zhang","year":"2024","unstructured":"Zhang X, Yi K, Wang B, Chu K, Liu J, Zhang J, et al. Ezh2 activates HTLV-1 Bzip factor-mediated Tgf-\u0392 signaling in Adult T-Cell Leukemia. J Med Virol. 2024;96(11):e70025. https:\/\/doi.org\/10.1002\/jmv.70025.","journal-title":"J Med Virol"},{"issue":"1","key":"485_CR242","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-019-0499-5","volume":"16","author":"Y Enose-Akahata","year":"2019","unstructured":"Enose-Akahata Y, Jacobson S. Immunovirological markers in HTLV-1-associated Myelopathy\/Tropical Spastic Paraparesis (Ham\/Tsp). Retrovirology. 2019;16(1):35. https:\/\/doi.org\/10.1186\/s12977-019-0499-5.","journal-title":"Retrovirology"},{"issue":"6","key":"485_CR243","doi-asserted-by":"publisher","DOI":"10.3390\/v8060161","volume":"8","author":"CZ Giam","year":"2016","unstructured":"Giam CZ, Semmes OJ. HTLV-1 infection and Adult T-Cell Leukemia\/Lymphoma-a tale of two proteins: Tax and HBZ. Viruses. 2016;8(6):161. https:\/\/doi.org\/10.3390\/v8060161.","journal-title":"Viruses"},{"issue":"10","key":"485_CR244","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1182\/blood-2016-02-698936","volume":"128","author":"H Miyoshi","year":"2016","unstructured":"Miyoshi H, Kiyasu J, Kato T, Yoshida N, Shimono J, Yokoyama S, et al. Pd-L1 expression on neoplastic or stromal cells is respectively a poor or good prognostic factor for Adult T-Cell Leukemia\/Lymphoma. Blood. 2016;128(10):1374\u201381. https:\/\/doi.org\/10.1182\/blood-2016-02-698936.","journal-title":"Blood"},{"key":"485_CR245","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100902","volume":"40","author":"N Nakano","year":"2023","unstructured":"Nakano N, Nakasone H, Fuji S, Shinohara A, Suzuki R, Utsunomiya A, et al. Outcomes in Human T-Cell Leukemia Virus Type I carriers after hematopoietic stem cell transplantation for diseases other than Adult T Cell Leukemia\/Lymphoma: a Japanese national survey. Lancet Reg Health West Pac. 2023;40:100902. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100902.","journal-title":"Lancet Reg Health West Pac"},{"key":"485_CR246","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1587802","volume":"15","author":"J Vasconez-Gonzalez","year":"2025","unstructured":"Vasconez-Gonzalez J, Su\u00e1rez-Sangucho IA, Acosta-Mu\u00f1oz E, Mi\u00f1o LPY, Borja-Mendoza D, Alexander-Castillo JA, et al. Human T-Cell Leukemia Virus Type 1: oncogenic potential and vaccine development strategies. Front Cell Infect Microbiol. 2025;15:1587802. https:\/\/doi.org\/10.3389\/fcimb.2025.1587802.","journal-title":"Front Cell Infect Microbiol"},{"key":"485_CR247","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.856363","volume":"13","author":"EH Joo","year":"2022","unstructured":"Joo EH, Bae JH, Park J, Bang YJ, Han J, Gulati N, et al. Deconvolution of Adult T-Cell Leukemia\/Lymphoma with single-cell Rna-Seq using frozen archived skin tissue reveals new subset of cancer-associated fibroblast. Front Immunol. 2022;13:856363. https:\/\/doi.org\/10.3389\/fimmu.2022.856363.","journal-title":"Front Immunol"},{"issue":"7203","key":"485_CR248","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428\u201335. https:\/\/doi.org\/10.1038\/nature07201.","journal-title":"Nature"},{"key":"485_CR249","doi-asserted-by":"publisher","first-page":"9114504","DOI":"10.1016\/j.addr.2022.114504","volume":"18","author":"R Rimal","year":"2022","unstructured":"Rimal R, Desai P, Daware R, Hosseinnejad A, Prakash J, Lammers T, et al. Cancer-Associated Fibroblasts: Origin, Function, Imaging, and Therapeutic Targeting. Adv Drug Deliv Rev. 2022;18:9114504. https:\/\/doi.org\/10.1016\/j.addr.2022.114504.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"485_CR250","doi-asserted-by":"publisher","DOI":"10.3892\/br.2024.1834.","volume":"21","author":"S Srisopa","year":"2024","unstructured":"Srisopa S, Pipatsatitpong D, Akekawatchai C. Association of serum lipid profile with liver fibrosis in HCV-coinfected HIV patients on suppressive anti-retroviral therapy. Biomed Rep. 2024;21(4):146. https:\/\/doi.org\/10.3892\/br.2024.1834.","journal-title":"Biomed Rep"},{"issue":"30","key":"485_CR251","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.3748\/wjg.v26.i30.4479","volume":"26","author":"C Zhou","year":"2020","unstructured":"Zhou C, Zhang N, He T-T, Wang Y, Wang L-F, Sun Y-Q, et al. High levels of serum Interleukin-6 increase mortality of Hepatitis B Virus-associated acute-on-chronic liver failure. World J Gastroenterol. 2020;26(30):4479. https:\/\/doi.org\/10.3748\/wjg.v26.i30.4479.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"485_CR252","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/jgh3.12778","volume":"6","author":"T Tada","year":"2022","unstructured":"Tada T, Kurosaki M, Tamaki N, Yasui Y, Mori N, Tsuji K, et al. General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with Hepatitis C Virus Genotype 1 or 2 after direct-acting antiviral therapy. JGH Open. 2022;6(7):487\u201395. https:\/\/doi.org\/10.1002\/jgh3.12778.","journal-title":"JGH Open"},{"issue":"6","key":"485_CR253","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.virs.2023.10.007","volume":"38","author":"L Wang","year":"2023","unstructured":"Wang L, Zeng X, Wang Z, Fang L, Liu J. Recent advances in understanding T Cell activation and exhaustion during HBV infection. Virol Sin. 2023;38(6):851\u20139. https:\/\/doi.org\/10.1016\/j.virs.2023.10.007.","journal-title":"Virol Sin"},{"issue":"5","key":"485_CR254","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.it.2025.03.007","volume":"46","author":"L Yuan","year":"2025","unstructured":"Yuan L, Zhong L, Krummenacher C, Zhao Q, Zhang X. Epstein\u2013Barr virus-mediated immune evasion in tumor promotion. Trends Immunol. 2025;46(5):386\u2013402. https:\/\/doi.org\/10.1016\/j.it.2025.03.007.","journal-title":"Trends Immunol"},{"issue":"12","key":"485_CR255","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.260682","volume":"136","author":"J Zhu","year":"2023","unstructured":"Zhu J, Chiang C, Gack MU. Viral evasion of the Interferon Response at a glance. J Cell Sci. 2023;136(12):jcs260682. https:\/\/doi.org\/10.1242\/jcs.260682.","journal-title":"J Cell Sci"},{"issue":"13","key":"485_CR256","doi-asserted-by":"publisher","first-page":"12543","DOI":"10.1007\/s00432-023-05083-5","volume":"149","author":"L Hao","year":"2023","unstructured":"Hao L, Li S, Hu X. New insights into T-Cell exhaustion in liver cancer: from mechanism to therapy. J Cancer Res Clin Oncol. 2023;149(13):12543\u201360. https:\/\/doi.org\/10.1007\/s00432-023-05083-5.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"485_CR257","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T Cell exhaustion. Nat Rev Immunol. 2015;15(8):486\u201399. https:\/\/doi.org\/10.1038\/nri3862.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"485_CR258","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01549-2","volume":"17","author":"KY Shen","year":"2024","unstructured":"Shen KY, Zhu Y, Xie SZ, Qin LX. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives. J Hematol Oncol. 2024;17(1):25. https:\/\/doi.org\/10.1186\/s13045-024-01549-2.","journal-title":"J Hematol Oncol"},{"key":"485_CR259","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","volume":"13","author":"T Duan","year":"2022","unstructured":"Duan T, Du Y, Xing C, Wang HY, Wang RF. Toll-Like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022;13:812774. https:\/\/doi.org\/10.3389\/fimmu.2022.812774.","journal-title":"Front Immunol"},{"issue":"8","key":"485_CR260","doi-asserted-by":"publisher","DOI":"10.3390\/v14081797","volume":"14","author":"CA Moody","year":"2022","unstructured":"Moody CA. Regulation of the innate immune response during the Human Papillomavirus life cycle. Viruses. 2022;14(8):1797. https:\/\/doi.org\/10.3390\/v14081797.","journal-title":"Viruses"},{"issue":"1","key":"485_CR261","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C, et al. Tgf-\u0392 signaling in health, disease, and therapeutics. Signal Transduct Target Ther. 2024;9(1):61. https:\/\/doi.org\/10.1038\/s41392-024-01764-w.","journal-title":"Signal Transduct Target Ther"},{"key":"485_CR262","doi-asserted-by":"publisher","first-page":"1582532","DOI":"10.3389\/fimmu.2025.1582532","volume":"16","author":"Associated Fibroblasts in Tumor Microenvironment","year":"2025","unstructured":"Associated Fibroblasts in Tumor Microenvironment. Front Immunol. 2025;16:1582532. https:\/\/doi.org\/10.3389\/fimmu.2025.1582532.","journal-title":"Front Immunol"},{"issue":"21","key":"485_CR263","doi-asserted-by":"publisher","DOI":"10.3390\/cells13211815","volume":"13","author":"C S\u00e1nchez-Mart\u00ednez","year":"2024","unstructured":"S\u00e1nchez-Mart\u00ednez C, Grueso E, Calvo-L\u00f3pez T, Martinez-Ortega J, Ruiz A, Almendral JM. Vegf-virus interactions: pathogenic mechanisms and therapeutic applications. Cells. 2024;13(21):1815. https:\/\/doi.org\/10.3390\/cells13211815.","journal-title":"Cells"},{"issue":"1","key":"485_CR264","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02208-3","volume":"24","author":"S He","year":"2025","unstructured":"He S, Zheng L, Qi C. Myeloid-derived suppressor cells (Mdscs) in the tumor microenvironment and their targeting in cancer therapy. Mol Cancer. 2025;24(1):5. https:\/\/doi.org\/10.1186\/s12943-024-02208-3.","journal-title":"Mol Cancer"},{"key":"485_CR265","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2025.199644","volume":"361","author":"RD Marca","year":"2025","unstructured":"Marca RD, Giugliano R, Zannella C, Acunzo M, Parimal P, Mali A, et al. Role of exosomes in viral infections: a narrative review. Virus Res. 2025;361:199644. https:\/\/doi.org\/10.1016\/j.virusres.2025.199644.","journal-title":"Virus Res"},{"issue":"8","key":"485_CR266","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30081763","volume":"30","author":"EY Kim","year":"2025","unstructured":"Kim EY, Abides J, Keller CR, Martinez SR, Li W. Tumor microenvironment lactate: is it a cancer progression marker, immunosuppressant, and therapeutic target? Molecules. 2025;30(8):1763. https:\/\/doi.org\/10.3390\/molecules30081763.","journal-title":"Molecules"},{"issue":"1","key":"485_CR267","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0743-4","volume":"12","author":"P Gao","year":"2019","unstructured":"Gao P, Lazare C, Cao C, Meng Y, Wu P, Zhi W, et al. Immune checkpoint inhibitors in the treatment of virus-associated cancers. J Hematol Oncol. 2019;12(1):58. https:\/\/doi.org\/10.1186\/s13045-019-0743-4.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"485_CR268","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3350\/cmh.2024.0469","volume":"30","author":"A Bertoletti","year":"2024","unstructured":"Bertoletti A, Tan AT. Engineering HBV-specific T Cells for the treatment of HBV-related HCC and HBV infection: past, present, and future. Editorial on \u201cGenetically-modified, redirected T Cells target Hepatitis B Surface Antigen-Positive hepatocytes and Hepatocellular Carcinoma lesions in a clinical setting.\u201d Clin Mol Hepatol. 2024;30(4):728\u201334. https:\/\/doi.org\/10.3350\/cmh.2024.0469.","journal-title":"Clin Mol Hepatol"},{"issue":"12","key":"485_CR269","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20(12):864\u201384. https:\/\/doi.org\/10.1038\/s41571-023-00825-3.","journal-title":"Nat Rev Clin Oncol"},{"key":"485_CR270","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070115","volume":"379","author":"L Rahangdale","year":"2022","unstructured":"Rahangdale L, Mungo C, O\u2019connor S, Chibwesha CJ, Brewer NT. Human Papillomavirus vaccination and cervical cancer risk. BMJ. 2022;379:e070115. https:\/\/doi.org\/10.1136\/bmj-2022-070115.","journal-title":"BMJ"},{"key":"485_CR271","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215652","volume":"536","author":"M Cao","year":"2022","unstructured":"Cao M, Fan J, Lu L, Fan C, Wang Y, Chen T, et al. Long term outcome of prevention of liver cancer by Hepatitis B vaccine: results from an Rct with 37 years. Cancer Lett. 2022;536:215652. https:\/\/doi.org\/10.1016\/j.canlet.2022.215652.","journal-title":"Cancer Lett"},{"issue":"5","key":"485_CR272","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009069.pub3","volume":"5","author":"M Arbyn","year":"2018","unstructured":"Arbyn M, Xu L, Simoens C, Martin-Hirsch PP. Prophylactic vaccination against Human Papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database Syst Rev. 2018;5(5):Cd009069. https:\/\/doi.org\/10.1002\/14651858.CD009069.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"485_CR273","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030391","volume":"8","author":"L Cheng","year":"2020","unstructured":"Cheng L, Wang Y, Du J. Human Papillomavirus vaccines: an updated review. Vaccines. 2020;8(3):391. https:\/\/doi.org\/10.3390\/vaccines8030391.","journal-title":"Vaccines"},{"issue":"32 Pt A","key":"485_CR274","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1016\/j.vaccine.2017.12.079","volume":"36","author":"J Schiller","year":"2018","unstructured":"Schiller J, Lowy D. Explanations for the high potency of HPV prophylactic vaccines. Vaccine. 2018;36(32 Pt A):4768\u201373. https:\/\/doi.org\/10.1016\/j.vaccine.2017.12.079.","journal-title":"Vaccine"},{"issue":"7","key":"485_CR275","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jama.298.7.743","volume":"298","author":"A Hildesheim","year":"2007","unstructured":"Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, et al. Effect of Human Papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298(7):743\u201353. https:\/\/doi.org\/10.1001\/jama.298.7.743.","journal-title":"JAMA"},{"issue":"9","key":"485_CR276","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10091560","volume":"10","author":"C Ventura","year":"2022","unstructured":"Ventura C, Lu\u00eds \u00c2, Soares CP, Venuti A, Paolini F, Pereira L, et al. The effectiveness of therapeutic vaccines for the treatment of cervical intraepithelial neoplasia 3: a systematic review and meta-analysis. Vaccines (Basel). 2022;10(9):1560. https:\/\/doi.org\/10.3390\/vaccines10091560.","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"485_CR277","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2020.12.007","volume":"32","author":"P Bossi","year":"2021","unstructured":"Bossi P, Chan AT, Licitra L, Trama A, Orlandi E, Hui EP, et al. Nasopharyngeal carcinoma: Esmo-Euracan clinical practice guidelines for diagnosis, treatment and follow-up(\u2020). Ann Oncol. 2021;32(4):452\u201365. https:\/\/doi.org\/10.1016\/j.annonc.2020.12.007.","journal-title":"Ann Oncol"},{"issue":"21","key":"485_CR278","doi-asserted-by":"publisher","first-page":"10142","DOI":"10.1128\/jvi.74.21.10142-10152.2000","volume":"74","author":"A Janz","year":"2000","unstructured":"Janz A, Oezel M, Kurzeder C, Mautner J, Pich D, Kost M, et al. Infectious Epstein-Barr Virus lacking major glycoprotein Bllf1 (Gp350\/220) demonstrates the existence of additional viral ligands. J Virol. 2000;74(21):10142\u201352. https:\/\/doi.org\/10.1128\/jvi.74.21.10142-10152.2000.","journal-title":"J Virol"},{"issue":"24","key":"485_CR279","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","volume":"25","author":"F Denamur","year":"2007","unstructured":"Denamur F, Peeters P, Dubin G, Denis M. Phase I\/Ii studies to evaluate safety and immunogenicity of a recombinant Gp350 Epstein-Barr Virus vaccine in healthy adults. Vaccine. 2007;25(24):4697\u2013705. https:\/\/doi.org\/10.1016\/j.vaccine.2007.04.008.","journal-title":"Vaccine"},{"issue":"12","key":"485_CR280","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/523813","volume":"196","author":"EM Sokal","year":"2007","unstructured":"Sokal EM, Hoppenbrouwers K, Vandermeulen C, Moutschen M, L\u00e9onard P, Moreels A, et al. Recombinant Gp350 vaccine for infectious mononucleosis: a Phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr Virus vaccine in healthy young adults. J Infect Dis. 2007;196(12):1749\u201353. https:\/\/doi.org\/10.1086\/523813.","journal-title":"J Infect Dis"},{"issue":"1","key":"485_CR281","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60836-9","volume":"16","author":"Y Nam","year":"2025","unstructured":"Nam Y, Gomez K, Reynier JB, Khamnei C, Aitken M, Zheng V, et al. Genomic landscape of virus-associated cancers. Nat Commun. 2025;16(1):5887. https:\/\/doi.org\/10.1038\/s41467-025-60836-9.","journal-title":"Nat Commun"},{"key":"485_CR282","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.533253","volume":"10","author":"SK Zhang","year":"2020","unstructured":"Zhang SK, Guo Z, Wang P, Kang LN, Jia MM, Wu ZN, et al. The potential benefits of HPV E6\/E7 Mrna test in cervical cancer screening in China. Front Oncol. 2020;10:533253. https:\/\/doi.org\/10.3389\/fonc.2020.533253.","journal-title":"Front Oncol"},{"issue":"4","key":"485_CR283","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccell.2025.02.002","volume":"43","author":"WKJ Lam","year":"2025","unstructured":"Lam WKJ, Kang G, Chan CML, Lee VCT, Ma ML, Zhou Q, et al. Fragmentomics profiling and quantification of plasma Epstein-Barr Virus DNA enhance prediction of future nasopharyngeal carcinoma. Cancer Cell. 2025;43(4):728-739.e5. https:\/\/doi.org\/10.1016\/j.ccell.2025.02.002.","journal-title":"Cancer Cell"},{"issue":"5","key":"485_CR284","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/infdis\/jiab597","volume":"226","author":"S Liu","year":"2022","unstructured":"Liu S, Deng R, Zhou B, Liang X, Liu Z, Peng J, et al. Association of serum Hepatitis B Virus RNA with hepatocellular carcinoma risk in chronic Hepatitis B patients under Nucleos(T)Ide analogues therapy. J Infect Dis. 2022;226(5):881\u201390. https:\/\/doi.org\/10.1093\/infdis\/jiab597.","journal-title":"J Infect Dis"},{"issue":"7","key":"485_CR285","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70467","volume":"97","author":"VA Marshall","year":"2025","unstructured":"Marshall VA, Knights SM, Cornejo Castro EM, Labo N, Liu I, Miley WJ, et al. Kaposi Sarcoma-Associated Herpesvirus sequencing in people living with HIV in the Southern United States reveals subtype diversity and multiple infections. J Med Virol. 2025;97(7):e70467. https:\/\/doi.org\/10.1002\/jmv.70467.","journal-title":"J Med Virol"},{"key":"485_CR286","doi-asserted-by":"publisher","unstructured":"Hussain I, Boza J, Lukande R, Ayanga R, Semeere A, Cesarman E, et al. Automated Detection of Kaposi Sarcoma-Associated Herpesvirus Infected Cells in Immunohistochemical Images of Skin Biopsies. Res Sq. 2024:rs.3.rs-4736178. https:\/\/doi.org\/10.21203\/rs.3.rs-4736178\/v1.","DOI":"10.21203\/rs.3.rs-4736178\/v1"},{"issue":"12","key":"485_CR287","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1172\/jci64116","volume":"122","author":"SJ Rodig","year":"2012","unstructured":"Rodig SJ, Cheng J, Wardzala J, Dorosario A, Scanlon JJ, Laga AC, et al. Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirus. J Clin Invest. 2012;122(12):4645\u201353. https:\/\/doi.org\/10.1172\/jci64116.","journal-title":"J Clin Invest"},{"issue":"1","key":"485_CR288","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00747-5","volume":"13","author":"K Jimbo","year":"2025","unstructured":"Jimbo K, Nojima M, Toriuchi K, Yamagishi M, Nakashima M, Yamano Y, et al. Long-term kinetics of proviral load in HTLV-1 carriers: defining risk for the development of adult T-Cell leukemia\/lymphoma. Biomark Res. 2025;13(1):34. https:\/\/doi.org\/10.1186\/s40364-025-00747-5.","journal-title":"Biomark Res"},{"issue":"1","key":"485_CR289","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01537-2","volume":"15","author":"S Salta","year":"2023","unstructured":"Salta S, Lobo J, Magalh\u00e3es B, Henrique R, Jer\u00f3nimo C. DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: A systematic review and meta-analysis. Clin Epigenetics. 2023;15(1):125. https:\/\/doi.org\/10.1186\/s13148-023-01537-2.","journal-title":"Clin Epigenetics"},{"key":"485_CR290","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.524928","volume":"10","author":"H Wang","year":"2020","unstructured":"Wang H, Zhang Y, Bai W, Wang B, Wei J, Ji R, et al. Feasibility of immunohistochemical P16 staining in the diagnosis of human papillomavirus infection in patients with squamous cell carcinoma of the head and neck: A systematic review and meta-analysis. Front Oncol. 2020;10:524928. https:\/\/doi.org\/10.3389\/fonc.2020.524928.","journal-title":"Front Oncol"},{"issue":"6","key":"485_CR291","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/gtmb.2014.0292","volume":"19","author":"W Huang","year":"2015","unstructured":"Huang W, Li T, Yang W, Chai X, Chen K, Wei L, et al. Analysis of DNA methylation in plasma for monitoring hepatocarcinogenesis. Genet Test Mol Biomarkers. 2015;19(6):295\u2013302. https:\/\/doi.org\/10.1089\/gtmb.2014.0292.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"4","key":"485_CR292","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2021.2377","volume":"15","author":"T Kawaguchi","year":"2021","unstructured":"Kawaguchi T, Ide T, Amano K, Arinaga-Hino T, Kuwahara R, Sano T, et al. Enhanced liver fibrosis score as a predictive marker for hepatocellular carcinoma development after Hepatitis C virus eradication. Mol Clin Oncol. 2021;15(4):215. https:\/\/doi.org\/10.3892\/mco.2021.2377.","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"485_CR293","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0587","volume":"5","author":"JY Xu","year":"2022","unstructured":"Xu JY, Wei XL, Ren C, Zhang Y, Hu YF, Li JY, et al. Association of plasma Epstein-Barr virus DNA with outcomes for patients with recurrent or metastatic nasopharyngeal carcinoma receiving Anti-Programmed Cell Death 1 immunotherapy. JAMA Netw Open. 2022;5(3):e220587. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.0587.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"485_CR294","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/j.1572-0241.2006.00647.x","volume":"101","author":"G Chen","year":"2006","unstructured":"Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol. 2006;101(8):1797\u2013803. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00647.x.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"485_CR295","doi-asserted-by":"publisher","first-page":"466","DOI":"10.7150\/ijms.23147","volume":"15","author":"K Nirei","year":"2018","unstructured":"Nirei K, Kanda T, Nakamura H, Matsuoka S, Takayama T, Sugitani M, et al. Persistent hepatic inflammation plays a role in hepatocellular carcinoma after sustained virological response in patients with HCV infection. Int J Med Sci. 2018;15(5):466\u201374. https:\/\/doi.org\/10.7150\/ijms.23147.","journal-title":"Int J Med Sci"},{"key":"485_CR296","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.oraloncology.2017.01.012","volume":"67","author":"J Lacau St Guily","year":"2017","unstructured":"Lacau St Guily J, Rousseau A, Baujat B, P\u00e9ri\u00e9 S, Schultz P, Barry B, et al. Oropharyngeal cancer prognosis by tumour HPV status in France: the multicentric Papillophar study. Oral Oncol. 2017;67:29\u201336. https:\/\/doi.org\/10.1016\/j.oraloncology.2017.01.012.","journal-title":"Oral Oncol"},{"issue":"1","key":"485_CR297","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01928-2","volume":"23","author":"H Liu","year":"2024","unstructured":"Liu H, Tang L, Li Y, Xie W, Zhang L, Tang H, et al. Nasopharyngeal carcinoma: current views on the tumor microenvironment\u2019s impact on drug resistance and clinical outcomes. Mol Cancer. 2024;23(1):20. https:\/\/doi.org\/10.1186\/s12943-023-01928-2.","journal-title":"Mol Cancer"},{"issue":"9","key":"485_CR298","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13090911","volume":"13","author":"CS Ng","year":"2025","unstructured":"Ng CS. Immunotherapy of Oncovirus-Induced Cancers: A Review on the Development and Efficacy of Targeted Vaccines. Vaccines (Basel). 2025;13(9):911. https:\/\/doi.org\/10.3390\/vaccines13090911.","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"485_CR299","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000013923","volume":"98","author":"X Xu","year":"2019","unstructured":"Xu X, Tan Y, Qian Y, Xue W, Wang Y, Du J, et al. Clinicopathologic and Prognostic Significance of Tumor-Infiltrating CD8+ T Cells in Patients with Hepatocellular Carcinoma: A Meta-Analysis. Medicine (Baltimore). 2019;98(2):e13923. https:\/\/doi.org\/10.1097\/md.0000000000013923.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"485_CR300","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01739-6","volume":"18","author":"S Dai","year":"2025","unstructured":"Dai S, Chen Y, Cai W, Dong S, Zhao J, Chen L, et al. Combination Immunotherapy in Hepatocellular Carcinoma: Synergies among Immune Checkpoints, Tkis, and Chemotherapy. J Hematol Oncol. 2025;18(1):85. https:\/\/doi.org\/10.1186\/s13045-025-01739-6.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"485_CR301","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02710-4","volume":"42","author":"L Liu","year":"2023","unstructured":"Liu L, Liu J, Li P, Luo J, Qin R, Peng Q, et al. Single-Cell Analysis Reveals HBV-Specific PD-1(+)CD8(+) Trm Cells in Tumor Borders Are Associated with HBV-Related Hepatic Damage and Fibrosis in HCC Patients. J Exp Clin Cancer Res. 2023;42(1):152. https:\/\/doi.org\/10.1186\/s13046-023-02710-4.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"485_CR302","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/jnci\/djy225","volume":"111","author":"L Hu","year":"2019","unstructured":"Hu L, Bell D, Antani S, Xue Z, Yu K, Horning MP, et al. An observational study of deep learning and automated evaluation of cervical images for cancer screening. JNCI J Natl Cancer Inst. 2019;111(9):923\u201332. https:\/\/doi.org\/10.1093\/jnci\/djy225.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"8","key":"485_CR303","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djz224","volume":"112","author":"BT Beaty","year":"2020","unstructured":"Beaty BT, Moon DH, Shen CJ, Amdur RJ, Weiss J, Grilley-Olson J, et al. Pik3ca Mutation in HPV-Associated Opscc Patients Receiving Deintensified Chemoradiation. J Natl Cancer Inst. 2020;112(8):855\u20138. https:\/\/doi.org\/10.1093\/jnci\/djz224.","journal-title":"J Natl Cancer Inst"},{"key":"485_CR304","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.974678","volume":"12","author":"SI Kim","year":"2022","unstructured":"Kim SI, Kang JW, Eun YG, Lee YC. Prediction of Survival in Oropharyngeal Squamous Cell Carcinoma Using Machine Learning Algorithms: A Study Based on the Surveillance, Epidemiology, and End Results Database. Front Oncol. 2022;12:974678. https:\/\/doi.org\/10.3389\/fonc.2022.974678.","journal-title":"Front Oncol"},{"key":"485_CR305","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1650377","volume":"15","author":"Y Yang","year":"2025","unstructured":"Yang Y, Shang N, Lu S, Li L, Xu P, Wang X, et al. Exploring the Prognostic Value of EBV DNA in Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy Using Ai-Based Modeling. Front Oncol. 2025;15:1650377. https:\/\/doi.org\/10.3389\/fonc.2025.1650377.","journal-title":"Front Oncol"},{"key":"485_CR306","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.899351","volume":"12","author":"B Gu","year":"2022","unstructured":"Gu B, Meng M, Bi L, Kim J, Feng DD, Song S. Prediction of 5-Year Progression-Free Survival in Advanced Nasopharyngeal Carcinoma with Pretreatment Pet\/Ct Using Multi-Modality Deep Learning-Based Radiomics. Front Oncol. 2022;12:899351. https:\/\/doi.org\/10.3389\/fonc.2022.899351.","journal-title":"Front Oncol"},{"issue":"11","key":"485_CR307","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-025-06345-0","volume":"151","author":"Y Li","year":"2025","unstructured":"Li Y, Qiao Z, Li Y, Feng Y, Wang X. Machine Learning-Based Hepatocellular Carcinoma Risk Prediction Model for Patients with HBV-Related Compensated Advanced Chronic Liver Disease. J Cancer Res Clin Oncol. 2025;151(11):285. https:\/\/doi.org\/10.1007\/s00432-025-06345-0.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"485_CR308","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.15626","volume":"3","author":"GN Ioannou","year":"2020","unstructured":"Ioannou GN, Tang W, Beste LA, Tincopa MA, Su GL, Van T, et al. Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients with Hepatitis C Cirrhosis. JAMA Netw Open. 2020;3(9):e2015626. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.15626.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"485_CR309","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/21691401.2023.2244998","volume":"51","author":"S Cheng","year":"2023","unstructured":"Cheng S, Li S, Yang P, Wang R, Zhou P, Li J. Dissecting the tumour immune microenvironment in Merkel Cell Carcinoma based on a machine learning framework. Artif Cells Nanomed Biotechnol. 2023;51(1):397\u2013407. https:\/\/doi.org\/10.1080\/21691401.2023.2244998.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"12","key":"485_CR310","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70105","volume":"96","author":"P Cano","year":"2024","unstructured":"Cano P, Seltzer T, Seltzer J, Peng A, Landis J, Pluta L, et al. Viral load measurements for Kaposi Sarcoma Herpesvirus (KSHV\/HHV8): review and an updated assay. J Med Virol. 2024;96(12):e70105. https:\/\/doi.org\/10.1002\/jmv.70105.","journal-title":"J Med Virol"},{"issue":"11","key":"485_CR311","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1002\/ijc.28894","volume":"135","author":"J Bohlius","year":"2014","unstructured":"Bohlius J, Valeri F, Maskew M, Prozesky H, Garone D, Sengayi M, et al. Kaposi\u2019s Sarcoma in HIV\u2010infected patients in South Africa: multicohort study in the antiretroviral therapy era. Int J Cancer. 2014;135(11):2644\u201352. https:\/\/doi.org\/10.1002\/ijc.28894.","journal-title":"Int J Cancer"},{"issue":"4","key":"485_CR312","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040691","volume":"16","author":"I Russo","year":"2024","unstructured":"Russo I, Marino D, Cozzolino C, Del Fiore P, Nerjaku F, Finotto S, et al. Kaposi\u2019s Sarcoma: evaluation of clinical features, treatment outcomes, and prognosis in a single-center retrospective case series. Cancers (Basel). 2024;16(4):691. https:\/\/doi.org\/10.3390\/cancers16040691.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"485_CR313","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11998-w","volume":"25","author":"Q Sun","year":"2025","unstructured":"Sun Q, Zhang K, Xu Y, Luo M, Yang Z, Liu Q, et al. Explainable machine learning for predicting clinical outcomes in HIV\/Tb co-infection: A comparative retrospective study. BMC Infect Dis. 2025;25(1):1589. https:\/\/doi.org\/10.1186\/s12879-025-11998-w.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"485_CR314","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1631\/jzus.B2300492","volume":"26","author":"H Ye","year":"2025","unstructured":"Ye H, Liao W, Pan J, Shi Y, Wang Q. Immune checkpoint blockade for cancer therapy: current progress and perspectives. J Zhejiang Univ Sci B. 2025;26(3):203\u201326. https:\/\/doi.org\/10.1631\/jzus.B2300492.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"6","key":"485_CR315","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","volume":"28","author":"L Galluzzi","year":"2015","unstructured":"Galluzzi L, Buqu\u00e9 A, Kepp O, Zitvogel L, Kroemer G. Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell. 2015;28(6):690\u2013714. https:\/\/doi.org\/10.1016\/j.ccell.2015.10.012.","journal-title":"Cancer Cell"},{"issue":"12","key":"485_CR316","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1001\/jama.2022.16464","volume":"328","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Han L, Wu L, Chen J, Sun H, Wen G, et al. Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial. JAMA. 2022;328(12):1223\u201332. https:\/\/doi.org\/10.1001\/jama.2022.16464.","journal-title":"JAMA"},{"issue":"12","key":"485_CR317","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1001\/jama.2022.16442","volume":"328","author":"NJ Choudhury","year":"2022","unstructured":"Choudhury NJ, Riely GJ. Serplulimab with chemotherapy in extensive-stage SCLC. JAMA. 2022;328(12):1205\u20137. https:\/\/doi.org\/10.1001\/jama.2022.16442.","journal-title":"JAMA"},{"issue":"10294","key":"485_CR318","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(21)00797-2.","journal-title":"Lancet"},{"issue":"10434","key":"485_CR319","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","volume":"403","author":"D Lorusso","year":"2024","unstructured":"Lorusso D, Xiang Y, Hasegawa K, Scambia G, Leiva M, Ramos-Elias P, et al. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial. Lancet. 2024;403(10434):1341\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(24)00317-9.","journal-title":"Lancet"},{"issue":"10463","key":"485_CR320","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/S0140-6736(24)02135-4","volume":"404","author":"X Wu","year":"2024","unstructured":"Wu X, Sun Y, Yang H, Wang J, Lou H, Li D, et al. Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China. Lancet. 2024;404(10463):1668\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(24)02135-4.","journal-title":"Lancet"},{"issue":"10","key":"485_CR321","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S1470-2045(23)00411-4","volume":"24","author":"X Gao","year":"2023","unstructured":"Gao X, Xu N, Li Z, Shen L, Ji K, Zheng Z, et al. Safety and antitumour activity of cadonilimab, an anti-PD-1\/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b\/2 trial. Lancet Oncol. 2023;24(10):1134\u201346. https:\/\/doi.org\/10.1016\/S1470-2045(23)00411-4.","journal-title":"Lancet Oncol"},{"issue":"7","key":"485_CR322","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1200\/JCO.20.02712","volume":"39","author":"FH Wang","year":"2021","unstructured":"Wang FH, Wei XL, Feng J, Li Q, Xu N, Hu XC, et al. Efficacy, safety, and correlative biomarkers of Toripalimab in previously treated recurrent or metastatic nasopharyngeal carcinoma: A phase II clinical trial (POLARIS-02). J Clin Oncol. 2021;39(7):704\u201312. https:\/\/doi.org\/10.1200\/JCO.20.02712.","journal-title":"J Clin Oncol"},{"key":"485_CR323","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2024.106723","volume":"151","author":"QY Chen","year":"2024","unstructured":"Chen QY, Guo SS, Luo Y, Qu S, Wu DH, Chen XZ, et al. Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study. Oral Oncol. 2024;151:106723. https:\/\/doi.org\/10.1016\/j.oraloncology.2024.106723.","journal-title":"Oral Oncol"},{"issue":"10","key":"485_CR324","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s43018-025-01018-w","volume":"6","author":"J Huang","year":"2025","unstructured":"Huang J, Theelen WSME, Belcaid Z, Najjar M, van der Geest D, Singh D, et al. Combination of pembrolizumab and radiotherapy induces systemic antitumor immune responses in immunologically cold non-small cell lung cancer. Nat Cancer. 2025;6(10):1676\u201392. https:\/\/doi.org\/10.1038\/s43018-025-01018-w.","journal-title":"Nat Cancer"},{"issue":"4","key":"485_CR325","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1470-2045(22)00097-3","volume":"23","author":"J Delyon","year":"2022","unstructured":"Delyon J, Biard L, Renaud M, Resche-Rigon M, Le Goff J, Dalle S, et al. PD-1 blockade with pembrolizumab in classic or endemic Kaposi\u2019s sarcoma: a multicentre, single-arm, phase 2 study. Lancet Oncol. 2022;23(4):491\u2013500. https:\/\/doi.org\/10.1016\/S1470-2045(22)00097-3.","journal-title":"Lancet Oncol"},{"issue":"19","key":"485_CR326","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1158\/1078-0432.CCR-23-0395","volume":"30","author":"SP D'Angelo","year":"2024","unstructured":"D\u2019Angelo SP, Lebb\u00e9 C, Nghiem P, Brohl AS, Mrowiec T, Leslie T, et al. Biomarker analyses investigating disease biology and associations with outcomes in the JAVELIN Merkel 200 trial of Avelumab in metastatic Merkel Cell Carcinoma. Clin Cancer Res. 2024;30(19):4352\u201362. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0395.","journal-title":"Clin Cancer Res"},{"issue":"823","key":"485_CR327","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adr3930","volume":"17","author":"G Li","year":"2025","unstructured":"Li G, Lou Y, Ma J, Cheng L, Yu H, Tsahouridis O, et al. Depletion of plasmacytoid dendritic cells rescues HIV-reactive stem-like CD8+ T cells during chronic HIV-1 infection. Sci Transl Med. 2025;17(823):eadr3930. https:\/\/doi.org\/10.1126\/scitranslmed.adr3930.","journal-title":"Sci Transl Med"},{"issue":"11","key":"485_CR328","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1038\/s41591-025-03993-0","volume":"31","author":"MN Ramgopal","year":"2025","unstructured":"Ramgopal MN, Lalezari JP, Pires Dos Santos AG, Krishnan P, Vaidya TR, Zhou F, et al. Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study. Nat Med. 2025;31(11):3879\u201388. https:\/\/doi.org\/10.1038\/s41591-025-03993-0.","journal-title":"Nat Med"},{"issue":"1","key":"485_CR329","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38407-7","volume":"14","author":"DW Lim","year":"2023","unstructured":"Lim DW, Kao HF, Suteja L, Li CH, Quah HS, Tan DS, et al. Clinical efficacy and biomarker analysis of dual PD-1\/CTLA-4 blockade in recurrent\/metastatic EBV-associated nasopharyngeal carcinoma. Nat Commun. 2023;14(1):2781. https:\/\/doi.org\/10.1038\/s41467-023-38407-7.","journal-title":"Nat Commun"},{"issue":"7","key":"485_CR330","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.annonc.2022.03.012","volume":"33","author":"A Zer","year":"2022","unstructured":"Zer A, Icht O, Yosef L, Avram D, Jacobi O, Fenig E, et al. Phase II single-arm study of nivolumab and ipilimumab (Nivo\/Ipi) in previously treated classical Kaposi sarcoma (cKS). Ann Oncol. 2022;33(7):720\u20137. https:\/\/doi.org\/10.1016\/j.annonc.2022.03.012.","journal-title":"Ann Oncol"},{"issue":"2","key":"485_CR331","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jhep.2024.07.017","volume":"82","author":"G Lau","year":"2025","unstructured":"Lau G, Abou-Alfa GK, Cheng AL, Sukeepaisarnjaroen W, Van Dao T, Kang YK, et al. Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. J Hepatol. 2025;82(2):258\u201367. https:\/\/doi.org\/10.1016\/j.jhep.2024.07.017.","journal-title":"J Hepatol"},{"issue":"10357","key":"485_CR332","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(22)01659-2","volume":"400","author":"S Kim","year":"2022","unstructured":"Kim S, Wuthrick E, Blakaj D, Eroglu Z, Verschraegen C, Thapa R, et al. Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial. Lancet. 2022;400(10357):1008\u201319. https:\/\/doi.org\/10.1016\/S0140-6736(22)01659-2.","journal-title":"Lancet"},{"issue":"1","key":"485_CR333","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13045-023-01499-1","volume":"16","author":"L Cai","year":"2023","unstructured":"Cai L, Li Y, Tan J, Xu L, Li Y. Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy. J Hematol Oncol. 2023;16(1):105. https:\/\/doi.org\/10.1186\/s13045-023-01499-1.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"485_CR334","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa2109970","volume":"386","author":"HA Tawbi","year":"2022","unstructured":"Tawbi HA, Schadendorf D, Lipson EJ, Ascierto PA, Matamala L, Castillo Guti\u00e9rrez E, et al. Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. N Engl J Med. 2022;386(1):24\u201334. https:\/\/doi.org\/10.1056\/NEJMoa2109970.","journal-title":"N Engl J Med"},{"issue":"4","key":"485_CR335","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1001\/jamaoncol.2024.6998","volume":"11","author":"CS Floudas","year":"2025","unstructured":"Floudas CS, Goswami M, Donahue RN, Pastor DM, Redman JM, Brownell I, et al. Novel combination immunotherapy and clinical activity in patients with HPV-associated cancers: A nonrandomized clinical trial. JAMA Oncol. 2025;11(4):394\u20139. https:\/\/doi.org\/10.1001\/jamaoncol.2024.6998.","journal-title":"JAMA Oncol"},{"issue":"5","key":"485_CR336","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-025-04009-z","volume":"74","author":"CS Floudas","year":"2025","unstructured":"Floudas CS, Goswami M, Donahue RN, Strauss J, Pastor DM, Redman JM, et al. PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic Human Papillomavirus-associated cancer. Cancer Immunol Immunother. 2025;74(5):155. https:\/\/doi.org\/10.1007\/s00262-025-04009-z.","journal-title":"Cancer Immunol Immunother"},{"issue":"10","key":"485_CR337","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-013158","volume":"13","author":"F Rosato","year":"2025","unstructured":"Rosato F, Santiago-Sanchez G, Fabian KP, Padget MR, Lee JK, Allen CT, et al. Combination of a novel TCR V\u03b2 chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor models. J Immunother Cancer. 2025;13(10):e013158. https:\/\/doi.org\/10.1136\/jitc-2025-013158.","journal-title":"J Immunother Cancer"},{"issue":"20","key":"485_CR338","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1056\/NEJMc1803181","volume":"378","author":"L Ratner","year":"2018","unstructured":"Ratner L, Waldmann TA, Janakiram M, Brammer JE. Rapid progression of Adult T-Cell Leukemia-Lymphoma after PD-1 inhibitor therapy. N Engl J Med. 2018;378(20):1947\u20138. https:\/\/doi.org\/10.1056\/NEJMc1803181.","journal-title":"N Engl J Med"},{"issue":"1","key":"485_CR339","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00725-5","volume":"14","author":"Y Chen","year":"2025","unstructured":"Chen Y, Xin Q, Qiu J, Zhu M, Li Z, Qiu J, et al. In vivo CAR-T cell engineering: concept, research progress, potential challenges and enhancement strategies. Exp Hematol Oncol. 2025;14(1):133. https:\/\/doi.org\/10.1186\/s40164-025-00725-5.","journal-title":"Exp Hematol Oncol"},{"issue":"10","key":"485_CR340","doi-asserted-by":"publisher","DOI":"10.3390\/biom15101407","volume":"15","author":"S Smirnov","year":"2025","unstructured":"Smirnov S, Zaritsky Y, Silonov S, Gavrilova A, Fonin A. Advancing CAR-T therapy for solid tumors: From barriers to clinical progress. Biomolecules. 2025;15(10):1407. https:\/\/doi.org\/10.3390\/biom15101407.","journal-title":"Biomolecules"},{"issue":"5","key":"485_CR341","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3324\/haematol.2024.286534","volume":"110","author":"S Liu","year":"2025","unstructured":"Liu S, An L, Yin Z, Lin Y, Ling Z, Deng B, et al. Five-year outcome of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation. Haematologica. 2025;110(5):1192\u20136. https:\/\/doi.org\/10.3324\/haematol.2024.286534.","journal-title":"Haematologica"},{"issue":"12","key":"485_CR342","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/s41409-018-0235-0","volume":"53","author":"A Avigdor","year":"2018","unstructured":"Avigdor A, Shouval R, Jacoby E, Davidson T, Shimoni A, Besser M, et al. CAR T cells induce a complete response in refractory Burkitt Lymphoma. Bone Marrow Transplant. 2018;53(12):1583\u20135. https:\/\/doi.org\/10.1038\/s41409-018-0235-0.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"485_CR343","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1080\/10428194.2022.2076853","volume":"63","author":"SJ Seitter","year":"2022","unstructured":"Seitter SJ, McClelland PH, Ahlman MA, Goff SL, Yang JC, McIntyre L, et al. Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center. Leuk Lymphoma. 2022;63(10):2469\u201373. https:\/\/doi.org\/10.1080\/10428194.2022.2076853.","journal-title":"Leuk Lymphoma"},{"issue":"25","key":"485_CR344","doi-asserted-by":"publisher","first-page":"01488","DOI":"10.1016\/j.jtct.2025.10.006","volume":"S2666\u20136367","author":"B Salter","year":"2025","unstructured":"Salter B, Suleman A, Kridel R, Trottier AM, Li R, Binnie M, et al. CAR-T for Management of R\/R PTLD Following Lung Transplant: A Multi-center Retrospective Study. Transplant Cell Ther. 2025;S2666\u20136367(25):01488\u201395. https:\/\/doi.org\/10.1016\/j.jtct.2025.10.006.","journal-title":"Transplant Cell Ther"},{"key":"485_CR345","doi-asserted-by":"publisher","first-page":"1491100","DOI":"10.3389\/fonc.2024.1491100","volume":"14","author":"D Kong","year":"2024","unstructured":"Kong D, Ping N, Zhu Q, Zhang X, Li J, Zou R, et al. Case report: CAR-T therapy demonstrated safety and efficacy in relapsed\/refractory diffuse large B-cell lymphoma patients complicated with hepatitis B-related cirrhosis. Front Oncol. 2024;14:1491100. https:\/\/doi.org\/10.3389\/fonc.2024.1491100.","journal-title":"Front Oncol"},{"issue":"8075","key":"485_CR346","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41586-025-09212-7","volume":"644","author":"AXY Chen","year":"2025","unstructured":"Chen AXY, Yap KM, Kim JS, Sek K, Huang YK, Dunbar PA, et al. Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery. Nature. 2025;644(8075):241\u201351. https:\/\/doi.org\/10.1038\/s41586-025-09212-7.","journal-title":"Nature"},{"issue":"1","key":"485_CR347","doi-asserted-by":"publisher","first-page":"2546404","DOI":"10.1080\/2162402X.2025.2546404","volume":"14","author":"F Wang","year":"2025","unstructured":"Wang F, Li J, Huang Y, Yan F, Gao H, Zhou W, et al. CAR-T cell engineered with TCR-like antibody specific for HBV surface antigen epitope E183\u201391\/HLA-A *0201 exhibit potent activity against HBV-HCC. Oncoimmunology. 2025;14(1):2546404. https:\/\/doi.org\/10.1080\/2162402X.2025.2546404.","journal-title":"Oncoimmunology"},{"issue":"8","key":"485_CR348","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1038\/s41591-024-03037-z","volume":"30","author":"C Qi","year":"2024","unstructured":"Qi C, Liu C, Gong J, Liu D, Wang X, Zhang P, et al. Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results. Nat Med. 2024;30(8):2224\u201334. https:\/\/doi.org\/10.1038\/s41591-024-03037-z.","journal-title":"Nat Med"},{"key":"485_CR349","doi-asserted-by":"publisher","first-page":"1213716","DOI":"10.3389\/fimmu.2023.1213716","volume":"14","author":"C Hu","year":"2023","unstructured":"Hu C, Liu M, Li Y, Zhao Y, Sharma A, Liu H, et al. Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer. Front Immunol. 2023;14:1213716. https:\/\/doi.org\/10.3389\/fimmu.2023.1213716.","journal-title":"Front Immunol"},{"key":"485_CR350","doi-asserted-by":"publisher","first-page":"1596583","DOI":"10.3389\/fimmu.2025.1596583","volume":"16","author":"H Aboaid","year":"2025","unstructured":"Aboaid H, Khalid T, Hussain A, Myat YM, Nanda RK, Srinivasmurthy R, et al. Advances and challenges in immunotherapy in head and neck cancer. Front Immunol. 2025;16:1596583. https:\/\/doi.org\/10.3389\/fimmu.2025.1596583.","journal-title":"Front Immunol"},{"key":"485_CR351","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.virol.2023.06.015","volume":"586","author":"G Guo","year":"2023","unstructured":"Guo G, He W, Zhou Z, Diao Y, Sui J, Li W. PreS1-targeting chimeric antigen receptor T cells diminish HBV infection in liver humanized FRG mice. Virology. 2023;586:23\u201334. https:\/\/doi.org\/10.1016\/j.virol.2023.06.015.","journal-title":"Virology"},{"key":"485_CR352","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1566976","volume":"16","author":"S Wu","year":"2025","unstructured":"Wu S, Gan X, Huang S, Zhong Y, Wu J, Yang H, et al. Application and prospect analysis of chimeric antigen receptor T-cell therapy in hepatocellular carcinoma treatment: a systematic review and meta-analysis. Front Immunol. 2025;16:1566976. https:\/\/doi.org\/10.3389\/fimmu.2025.1566976.","journal-title":"Front Immunol"},{"issue":"7662","key":"485_CR353","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature23003","volume":"547","author":"U Sahin","year":"2017","unstructured":"Sahin U, Derhovanessian E, Miller M, Kloke BP, Simon P, L\u00f6wer M, et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017;547(7662):222\u20136. https:\/\/doi.org\/10.1038\/nature23003.","journal-title":"Nature"},{"issue":"4","key":"485_CR354","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1021\/acs.molpharmaceut.4c00871","volume":"22","author":"PB Tiwade","year":"2025","unstructured":"Tiwade PB, Fung V, VanKeulen-Miller R, Narasipura EA, Ma Y, Fenton OS. Non-viral RNA therapies for non-small cell lung cancer and their corresponding clinical trials. Mol Pharm. 2025;22(4):1752\u201374. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00871.","journal-title":"Mol Pharm"},{"issue":"9","key":"485_CR355","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41422-024-00990-9","volume":"34","author":"X Wang","year":"2024","unstructured":"Wang X, Wang W, Zou S, Xu Z, Cao D, Zhang S, et al. Combination therapy of KRAS G12V mRNA vaccine and Pembrolizumab: clinical benefit in patients with advanced solid tumors. Cell Res. 2024;34(9):661\u20134. https:\/\/doi.org\/10.1038\/s41422-024-00990-9.","journal-title":"Cell Res"},{"issue":"9","key":"485_CR356","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012090","volume":"13","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Cao B, Li L, Zhou Y, Ni C, Zhao Y, et al. mRNA-encoded mutant HPV16\/18 vaccines promote specific T-cell responses and synergize with anti-PD-1 checkpoint blockade in mediating therapeutic tumor regression in mice. J Immunother Cancer. 2025;13(9):e012090. https:\/\/doi.org\/10.1136\/jitc-2025-012090.","journal-title":"J Immunother Cancer"},{"issue":"Pt 2","key":"485_CR357","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.148933","volume":"333","author":"G Lin","year":"2025","unstructured":"Lin G, Guo X, Fu Z, Liu Z, Gu F, Yan H, et al. Self-amplifying mRNA nanovaccine encoding GM-CSF-fused HPV16 E7 enhances immunogenicity and therapeutic efficacy against cervical cancer. Int J Biol Macromol. 2025;333(Pt 2):148933. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148933.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"485_CR358","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2025.200986","volume":"33","author":"K Huang","year":"2025","unstructured":"Huang K, Lin XJ, Hu JC, Xia TY, Xu FP, Huang JD, et al. Epstein-Barr virus mRNA vaccine synergizes with NK cells to enhance nasopharyngeal carcinoma eradication in humanized mice. Mol Ther Oncol. 2025;33(2):200986. https:\/\/doi.org\/10.1016\/j.omton.2025.200986.","journal-title":"Mol Ther Oncol"},{"issue":"1","key":"485_CR359","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48031-8","volume":"15","author":"M Wu","year":"2024","unstructured":"Wu M, Hau PM, Li L, Tsang CM, Yang Y, Taghbalout A, et al. Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers. Nat Commun. 2024;15(1):3729. https:\/\/doi.org\/10.1038\/s41467-024-48031-8.","journal-title":"Nat Commun"},{"issue":"1","key":"485_CR360","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-025-00573-1","volume":"19","author":"H Choi","year":"2025","unstructured":"Choi H, Lee S, Kim H, Bae SH, Jo S, Kim J, et al. Integration of TLR7\/8 agonists into lipid nanoparticles enhances antigen-specific immune responses to N1-methyl-\u03a8-modified mRNA-LNP vaccines. J Biol Eng. 2025;19(1):103. https:\/\/doi.org\/10.1186\/s13036-025-00573-1.","journal-title":"J Biol Eng"},{"issue":"4","key":"485_CR361","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1261\/rna.049882.115","volume":"21","author":"BR Cullen","year":"2015","unstructured":"Cullen BR. The virology-RNA biology connection. RNA. 2015;21(4):592\u20134. https:\/\/doi.org\/10.1261\/rna.049882.115.","journal-title":"RNA"},{"key":"485_CR362","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.108190","volume":"210","author":"S Blanco","year":"2026","unstructured":"Blanco S, Lingua G, Del Pilar G\u00f3mez L, Mangeaud A, Gallego SV. Neutralizing antibodies and the pathogenesis of HTLV-1: insights from clinical cohorts. Microb Pathog. 2026;210:108190. https:\/\/doi.org\/10.1016\/j.micpath.2025.108190.","journal-title":"Microb Pathog"},{"issue":"18","key":"485_CR363","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1039\/d2sc01672a","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Xiao X, Feng Y, Li J, Zhang Y. A photoresponsive antibody-siRNA conjugate for activatable immunogene therapy of cancer. Chem Sci. 2022;13(18):5345\u201352. https:\/\/doi.org\/10.1039\/d2sc01672a.","journal-title":"Chem Sci"},{"key":"485_CR364","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.148904","volume":"932","author":"R Rasizadeh","year":"2025","unstructured":"Rasizadeh R, Shiri Aghbash P, Mokhtarzadeh A, Poortahmasebi V, Ahangar Oskouee M, Sadri Nahand J, et al. Novel strategies in HPV 16 related cervical cancer treatment: an in vitro study of combined siRNA-E5 with oxaliplatin and ifosfamide chemotherapy. Gene. 2025;932:148904. https:\/\/doi.org\/10.1016\/j.gene.2024.148904.","journal-title":"Gene"},{"key":"485_CR365","doi-asserted-by":"publisher","DOI":"10.1177\/09603271241261307","volume":"43","author":"C Zhao","year":"2024","unstructured":"Zhao C, Tang Q, Yang C, Zhou L, Peng J, Zhang T, et al. Stereotactic body radiation therapy suppresses myeloid-derived suppressor cells by regulating miR-21\/Sorbin and SH3 Domain-containing Protein 1 axis. Hum Exp Toxicol. 2024;43:9603271241261307. https:\/\/doi.org\/10.1177\/09603271241261307.","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"485_CR366","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01771-3","volume":"25","author":"A Azani","year":"2025","unstructured":"Azani A, Sharafi M, Doachi R, Akbarzadeh S, Lorestani P, Haji Kamanaj Olia A, et al. Applications of CRISPR-Cas9 in mitigating cellular senescence and age-related disease progression. Clin Exp Med. 2025;25(1):237. https:\/\/doi.org\/10.1007\/s10238-025-01771-3.","journal-title":"Clin Exp Med"},{"key":"485_CR367","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1200\/JCO.2024.42.16_suppl.2549","volume":"42","author":"J Guo","year":"2024","unstructured":"Guo J, Huang W, Zhao B, Yu J, Cui J, Sun J, et al. A first-in-human study of CRISPR\/Cas9-engineered tumor infiltrating lymphocytes (TILs) product GT316 as monotherapy in advanced solid tumors. J Clin Oncol. 2024;42:2549\u20132549. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.2549.","journal-title":"J Clin Oncol"},{"key":"485_CR368","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-019-0246-5","volume":"14","author":"H Huo","year":"2019","unstructured":"Huo H, Hu G. CRISPR\/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth. Infect Agents Cancer. 2019;14:30. https:\/\/doi.org\/10.1186\/s13027-019-0246-5.","journal-title":"Infect Agents Cancer"},{"issue":"10","key":"485_CR369","doi-asserted-by":"publisher","first-page":"8419","DOI":"10.1002\/jcb.27050","volume":"119","author":"J Song","year":"2018","unstructured":"Song J, Zhang X, Ge Q, Yuan C, Chu L, Liang HF, et al. CRISPR\/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells. J Cell Biochem. 2018;119(10):8419\u201331. https:\/\/doi.org\/10.1002\/jcb.27050.","journal-title":"J Cell Biochem"},{"issue":"9","key":"485_CR370","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110854","volume":"27","author":"DE Tsai","year":"2024","unstructured":"Tsai DE, Lovanov A, Abdelmaksoud A, Akhtar J, Dar MS, Luff M, et al. Smyd3-mediated immuno-modulation in HPV-negative head and neck squamous cell carcinoma mouse models. iScience. 2024;27(9):110854. https:\/\/doi.org\/10.1016\/j.isci.2024.110854.","journal-title":"iScience"},{"issue":"4","key":"485_CR371","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","volume":"181","author":"TR Abbott","year":"2020","unstructured":"Abbott TR, Dhamdhere G, Liu Y, Lin X, Goudy L, Zeng L, et al. Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and Influenza. Cell. 2020;181(4):865-876.e12. https:\/\/doi.org\/10.1016\/j.cell.2020.04.020.","journal-title":"Cell"},{"issue":"1","key":"485_CR372","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03014-x","volume":"43","author":"S Camorani","year":"2024","unstructured":"Camorani S, Caliendo A, Morrone E, Agnello L, Martini M, Cantile M, et al. Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies. J Exp Clin Cancer Res. 2024;43(1):243. https:\/\/doi.org\/10.1186\/s13046-024-03014-x.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"485_CR373","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/nat.2017.0687","volume":"28","author":"DG Valencia-Res\u00e9ndiz","year":"2018","unstructured":"Valencia-Res\u00e9ndiz DG, Palomino-Vizcaino G, Tapia-Vieyra JV, Ben\u00edtez-Hess ML, Leija-Montoya AG, Alvarez-Salas LM. Inhibition of Human Papillomavirus Type 16 infection using an RNA aptamer. Nucleic Acid Ther. 2018;28(2):97\u2013105. https:\/\/doi.org\/10.1089\/nat.2017.0687.","journal-title":"Nucleic Acid Ther"},{"issue":"7","key":"485_CR374","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.3390\/v7072780","volume":"7","author":"\u00d6 Cesur","year":"2015","unstructured":"Cesur \u00d6, Nicol C, Groves H, Mankouri J, Blair GE, Stonehouse NJ. The Subcellular Localisation of the Human Papillomavirus (HPV) 16 E7 Protein in Cervical Cancer Cells and Its Perturbation by RNA Aptamers. Viruses. 2015;7(7):3443\u201361. https:\/\/doi.org\/10.3390\/v7072780.","journal-title":"Viruses"},{"issue":"5","key":"485_CR375","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202417247","volume":"64","author":"D Ji","year":"2025","unstructured":"Ji D, Wang B, Lo KW, Tsang CM, Kwok CK. Pre-Defined Stem-Loop Structure Library for the Discovery of L-RNA Aptamers that Target RNA G-Quadruplexes. Angew Chem Int Ed Engl. 2025;64(5):e202417247. https:\/\/doi.org\/10.1002\/anie.202417247.","journal-title":"Angew Chem Int Ed Engl"},{"key":"485_CR376","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.152975","volume":"792","author":"J Xu","year":"2025","unstructured":"Xu J, Liu Y, Luo F, Zhao J. Silent CD24-engineered oncolytic virus vaccine enhances antitumor immunity. Biochem Biophys Res Commun. 2025;792:152975. https:\/\/doi.org\/10.1016\/j.bbrc.2025.152975.","journal-title":"Biochem Biophys Res Commun"},{"key":"485_CR377","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/bs.apcsb.2024.10.012","volume":"144","author":"S Kar","year":"2025","unstructured":"Kar S, Mehrotra S, Prajapati VK. From infection to remedy: Harnessing oncolytic viruses in cancer treatment. Adv Protein Chem Struct Biol. 2025;144:213\u201357. https:\/\/doi.org\/10.1016\/bs.apcsb.2024.10.012.","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"6","key":"485_CR378","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115745","volume":"44","author":"K Zhang","year":"2025","unstructured":"Zhang K, Zuo D, Wang Z, Ding J, Xu J, Liu Y, et al. Heterologous prime-boost with an mRNA vaccine and an oncolytic virus enhances tumor regression through overcoming intratumoral immune suppression. Cell Rep. 2025;44(6):115745. https:\/\/doi.org\/10.1016\/j.celrep.2025.115745.","journal-title":"Cell Rep"},{"issue":"6","key":"485_CR379","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s10120-025-01664-0","volume":"28","author":"SH Lee","year":"2025","unstructured":"Lee SH, Byun H, Seo D, Cho M, Kim JH, Kang BW, et al. Development of adenovirus-based oncolytic virus to induce EBV lytic reactivation. Gastric Cancer. 2025;28(6):1125\u201343. https:\/\/doi.org\/10.1007\/s10120-025-01664-0.","journal-title":"Gastric Cancer"},{"issue":"8062","key":"485_CR380","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-025-08717-5","volume":"641","author":"Y Shen","year":"2025","unstructured":"Shen Y, Bai X, Zhang Q, Liang X, Jin X, Zhao Z, et al. Oncolytic virus VG161 in refractory hepatocellular carcinoma. Nature. 2025;641(8062):503\u201311. https:\/\/doi.org\/10.1038\/s41586-025-08717-5.","journal-title":"Nature"},{"issue":"4","key":"485_CR381","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2024.12.010","volume":"188","author":"L Zhong","year":"2025","unstructured":"Zhong L, Gan L, Wang B, Wu T, Yao F, Gong W, et al. Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients. Cell. 2025;188(4):1119-1136.e23. https:\/\/doi.org\/10.1016\/j.cell.2024.12.010.","journal-title":"Cell"},{"issue":"1","key":"485_CR382","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41523-025-00842-8","volume":"11","author":"LA Huppert","year":"2025","unstructured":"Huppert LA, Gliwa AS, Tait M, Quintal L, Starzinski S, Cheung A, et al. Phase Ib study of intratumoral talimogene laherparepvec (T-VEC) in combination with chemotherapy or endocrine therapy in patients with advanced HER2-negative breast cancer. NPJ breast cancer. 2025;11(1):130. https:\/\/doi.org\/10.1038\/s41523-025-00842-8.","journal-title":"NPJ breast cancer"},{"issue":"1","key":"485_CR383","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13048-022-01074-1","volume":"16","author":"Z Wang","year":"2023","unstructured":"Wang Z, Zhang J, Dai F, Li B, Cheng Y. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer. Journal of ovarian research. 2023;16(1):12. https:\/\/doi.org\/10.1186\/s13048-022-01074-1.","journal-title":"Journal of ovarian research"},{"issue":"4","key":"485_CR384","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0322326","volume":"20","author":"C Zhong","year":"2025","unstructured":"Zhong C, Zhong L. Integrated bulk RNA and single-cell analysis with experimental validation reveal oxidative stress-related diagnostic biomarkers for osteoporosis. PLoS ONE. 2025;20(4):e0322326. https:\/\/doi.org\/10.1371\/journal.pone.0322326.","journal-title":"PLoS ONE"},{"key":"485_CR385","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1591531","volume":"12","author":"X Huang","year":"2025","unstructured":"Huang X, Lu S, Li X, Wu J, Zu Q, Duan Z, et al. Multi-omics profiling reveals the role of 4-ethylbenzoic acid in promoting proliferation and invasion of cervical cancer. Front Med. 2025;12:1591531. https:\/\/doi.org\/10.3389\/fmed.2025.1591531.","journal-title":"Front Med"},{"issue":"5","key":"485_CR386","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28789","volume":"95","author":"X Zeng","year":"2023","unstructured":"Zeng X, Wang Y, Liu B, Rao X, Cao C, Peng F, et al. Multi-omics data reveals novel impacts of Human Papillomavirus integration on the epigenomic and transcriptomic signatures of cervical tumorigenesis. J Med Virol. 2023;95(5):e28789. https:\/\/doi.org\/10.1002\/jmv.28789.","journal-title":"J Med Virol"},{"key":"485_CR387","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1612623","volume":"16","author":"Q Su","year":"2025","unstructured":"Su Q, Tian X, Li F, Yu X, Gong W, Chen Y, et al. Integrated multi-omics analysis of single-cell and spatial transcriptomics reveals distinct HPV-associated immune microenvironment features and prognostic signatures in cervical cancer. Front Immunol. 2025;16:1612623. https:\/\/doi.org\/10.3389\/fimmu.2025.1612623.","journal-title":"Front Immunol"},{"issue":"19","key":"485_CR388","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71278","volume":"14","author":"S Yao","year":"2025","unstructured":"Yao S, Chen S, Wan S, Wang A, Liang Z, Liu X, et al. LAG3 as a tumor suppressor and immune regulator in cervical cancer: from functional validation to therapeutic strategy. Cancer Med. 2025;14(19):e71278. https:\/\/doi.org\/10.1002\/cam4.71278.","journal-title":"Cancer Med"},{"issue":"3","key":"485_CR389","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1219","volume":"13","author":"C Guo","year":"2023","unstructured":"Guo C, Qu X, Tang X, Song Y, Wang J, Hua K, et al. Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: integrating single-cell RNA-sequencing and spatial transcriptome. Clin Transl Med. 2023;13(3):e1219. https:\/\/doi.org\/10.1002\/ctm2.1219.","journal-title":"Clin Transl Med"},{"issue":"1","key":"485_CR390","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00948-z","volume":"9","author":"P Xia","year":"2025","unstructured":"Xia P, Zhou J, Shen R, Wang D. Deciphering the cellular and molecular landscape of cervical cancer progression through single-cell and spatial transcriptomics. NPJ Precis Oncol. 2025;9(1):158. https:\/\/doi.org\/10.1038\/s41698-025-00948-z.","journal-title":"NPJ Precis Oncol"},{"issue":"37","key":"485_CR391","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1038\/onc.2014.32","volume":"33","author":"L Xiao","year":"2014","unstructured":"Xiao L, Hu ZY, Dong X, Tan Z, Li W, Tang M, et al. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy. Oncogene. 2014;33(37):4568\u201378. https:\/\/doi.org\/10.1038\/onc.2014.32.","journal-title":"Oncogene"},{"issue":"11","key":"485_CR392","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41422-020-0374-x","volume":"30","author":"YP Chen","year":"2020","unstructured":"Chen YP, Yin JH, Li WF, Li HJ, Chen DP, Zhang CJ, et al. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. Cell Res. 2020;30(11):1024\u201342. https:\/\/doi.org\/10.1038\/s41422-020-0374-x.","journal-title":"Cell Res"},{"issue":"1","key":"485_CR393","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52153-4","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y, Ye SY, He S, Chi DM, Wang XZ, Wen YF, et al. Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma. Nat Commun. 2024;15(1):7713. https:\/\/doi.org\/10.1038\/s41467-024-52153-4.","journal-title":"Nat Commun"},{"issue":"1","key":"485_CR394","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jhep.2023.09.039","volume":"80","author":"G Guan","year":"2024","unstructured":"Guan G, Zhang T, Ning J, Tao C, Gao N, Zeng Z, et al. Higher TP53BP2 expression is associated with HBsAg loss in peginterferon-\u03b1-treated patients with chronic hepatitis B. J Hepatol. 2024;80(1):41\u201352. https:\/\/doi.org\/10.1016\/j.jhep.2023.09.039.","journal-title":"J Hepatol"},{"key":"485_CR395","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.955390","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang L, Ju X, Wang S, Qie J. Single-cell transcriptomic analysis reveals macrophage-tumor crosstalk in hepatocellular carcinoma. Front Immunol. 2022;13:955390. https:\/\/doi.org\/10.3389\/fimmu.2022.955390.","journal-title":"Front Immunol"},{"issue":"1","key":"485_CR396","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01619-5","volume":"22","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Zhao Y, Ning Z, Deng Y, Li B, Sun Y, et al. Metabolic self-feeding in HBV-associated hepatocarcinoma centered on feedback between circulation lipids and the cellular MAPK\/mTOR axis. Cell Commun Signal. 2024;22(1):280. https:\/\/doi.org\/10.1186\/s12964-024-01619-5.","journal-title":"Cell Commun Signal"},{"issue":"9","key":"485_CR397","doi-asserted-by":"publisher","DOI":"10.1002\/biot.70112","volume":"20","author":"MYM Wu","year":"2025","unstructured":"Wu MYM, Rocamora F, Robinson CM, Shin S, Maurya S, Toth EA, et al. Enhanced production of HCV E1E2 subunit vaccine candidates via protein-protein interaction identification in glycoengineered CHO cells. Biotechnol J. 2025;20(9):e70112. https:\/\/doi.org\/10.1002\/biot.70112.","journal-title":"Biotechnol J"},{"issue":"1","key":"485_CR398","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06861-0","volume":"23","author":"J Zhang","year":"2025","unstructured":"Zhang J, Pan Y, Zhao Z, Chen B, Fan W, Zhao S, et al. SLC16A3 as an immunosuppressive Kupffer cell marker predicts poor prognosis in HBV-positive hepatocellular carcinoma. J Transl Med. 2025;23(1):988. https:\/\/doi.org\/10.1186\/s12967-025-06861-0.","journal-title":"J Transl Med"},{"issue":"1","key":"485_CR399","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12072-023-10615-9","volume":"18","author":"CL Yang","year":"2024","unstructured":"Yang CL, Song R, Hu JW, Huang JT, Li NN, Ni HH, et al. Integrating single-cell and bulk RNA sequencing reveals CK19+cancer stem cells and their specific SPP1+tumor-associated macrophage niche in HBV-related hepatocellular carcinoma. Hepatol Int. 2024;18(1):73\u201390. https:\/\/doi.org\/10.1007\/s12072-023-10615-9.","journal-title":"Hepatol Int"},{"issue":"5","key":"485_CR400","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/gutjnl-2023-330577","volume":"73","author":"X Yu","year":"2024","unstructured":"Yu X, Gong Q, Yu D, Chen Y, Jing Y, Zoulim F, et al. Spatial transcriptomics reveals a low extent of transcriptionally active hepatitis B virus integration in patients with HBsAg loss. Gut. 2024;73(5):797\u2013809. https:\/\/doi.org\/10.1136\/gutjnl-2023-330577.","journal-title":"Gut"},{"issue":"13","key":"485_CR401","doi-asserted-by":"publisher","first-page":"7720","DOI":"10.1093\/nar\/gkae540","volume":"52","author":"R Shekhar","year":"2024","unstructured":"Shekhar R, O\u2019Grady T, Keil N, Feswick A, Amador DAM, Tibbetts SA, et al. High-density resolution of the Kaposi\u2019s sarcoma associated herpesvirus transcriptome identifies novel transcript isoforms generated by long-range transcription and alternative splicing. Nucleic Acids Res. 2024;52(13):7720\u201339. https:\/\/doi.org\/10.1093\/nar\/gkae540.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"485_CR402","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04801-4","volume":"21","author":"V Caponigro","year":"2023","unstructured":"Caponigro V, Tornesello AL, Merciai F, La Gioia D, Salviati E, Basilicata MG, et al. Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patients. J Transl Med. 2023;21(1):918. https:\/\/doi.org\/10.1186\/s12967-023-04801-4.","journal-title":"J Transl Med"},{"issue":"2","key":"485_CR403","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jhep.2023.02.040","volume":"80","author":"A Cui","year":"2024","unstructured":"Cui A, Li B, Wallace MS, Gonye ALK, Oetheimer C, Patel H, et al. Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis. J Hepatol. 2024;80(2):251\u201367. https:\/\/doi.org\/10.1016\/j.jhep.2023.02.040.","journal-title":"J Hepatol"},{"issue":"11","key":"485_CR404","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1158\/1541-7786.MCR-24-1138","volume":"23","author":"JD Smith","year":"2025","unstructured":"Smith JD, Bhangale AD, Gu W, Brummel C, Gensterblum-Miller E, McLean S, et al. Genomic signatures of poor prognosis in Merkel cell carcinoma: a single-institution prospective study. Mol Cancer Res. 2025;23(11):923\u201335. https:\/\/doi.org\/10.1158\/1541-7786.MCR-24-1138.","journal-title":"Mol Cancer Res"},{"issue":"3","key":"485_CR405","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15062","volume":"33","author":"M Nakamura","year":"2024","unstructured":"Nakamura M, Yoshimitsu M, Magara T, Kano S, Kato H, Morita A. Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression. Exp Dermatol. 2024;33(3):e15062. https:\/\/doi.org\/10.1111\/exd.15062.","journal-title":"Exp Dermatol"},{"issue":"12","key":"485_CR406","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285233","volume":"109","author":"CS Myers","year":"2024","unstructured":"Myers CS, Williams E, Cornejo CB, Pongas G, Toomey NL, Sanches JA, et al. Distinctive genomic features of human T-lymphotropic virus type 1-related adult T-cell leukemia-lymphoma in Western populations. Haematologica. 2024;109(12):402139. https:\/\/doi.org\/10.3324\/haematol.2024.285233.","journal-title":"Haematologica"},{"issue":"1","key":"485_CR407","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63325-1","volume":"16","author":"S Sarkis","year":"2025","unstructured":"Sarkis S, Gutowska A, Rahman MA, Schifanella L, Goldfarbmuren KC, Bissa M, et al. High expression of Rex-orf-I and HBZ mRNAs and bronchiectasis in lung of HTLV-1A\/C infected macaques. Nat Commun. 2025;16(1):8470. https:\/\/doi.org\/10.1038\/s41467-025-63325-1.","journal-title":"Nat Commun"},{"issue":"1","key":"485_CR408","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59833-9","volume":"16","author":"PK Ehrenberg","year":"2025","unstructured":"Ehrenberg PK, Geretz A, Volcic M, Izumi T, Yum LK, Waickman A, et al. Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts. Nat Commun. 2025;16(1):4975. https:\/\/doi.org\/10.1038\/s41467-025-59833-9.","journal-title":"Nat Commun"},{"issue":"36","key":"485_CR409","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405210121","volume":"121","author":"AA Capoferri","year":"2024","unstructured":"Capoferri AA, Wiegand A, Hong F, Jacobs JL, Spindler J, Musick A, et al. HIV-1 control in vivo is related to the number but not the fraction of infected cells with viral unspliced RNA. Proc Natl Acad Sci U S A. 2024;121(36):e2405210121. https:\/\/doi.org\/10.1073\/pnas.2405210121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"485_CR410","doi-asserted-by":"publisher","first-page":"6721","DOI":"10.1073\/pnas.1805728115","volume":"115","author":"Y Yang","year":"2018","unstructured":"Yang Y, Qu N, Tan J, Rushdi MN, Krueger CJ, Chen AK. Roles of Gag-RNA interactions in HIV-1 virus assembly deciphered by single-molecule localization microscopy. Proc Natl Acad Sci U S A. 2018;115(26):6721\u20136. https:\/\/doi.org\/10.1073\/pnas.1805728115.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"485_CR411","doi-asserted-by":"publisher","DOI":"10.3791\/50386","volume":"76","author":"S Jun","year":"2013","unstructured":"Jun S, Zhao G, Ning J, Gibson GA, Watkins SC, Zhang P. Correlative microscopy for 3D structural analysis of dynamic interactions. J Vis Exp. 2013;76:50386. https:\/\/doi.org\/10.3791\/50386.","journal-title":"J Vis Exp"},{"issue":"3","key":"485_CR412","doi-asserted-by":"publisher","DOI":"10.1002\/mef2.94","volume":"3","author":"P Zhang","year":"2024","unstructured":"Zhang P, Wang Z, Yang Y, Duan S, Dou S, Sun H, et al. Cell\u2010type\u2010specific mRNA m6A landscape and regulatory mechanisms underlying pulmonary injury in COVID\u201019. MedComm-Future Med. 2024;3(3):e94. https:\/\/doi.org\/10.1002\/mef2.94.","journal-title":"MedComm-Future Med"},{"issue":"7924","key":"485_CR413","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","volume":"608","author":"C Kuppe","year":"2022","unstructured":"Kuppe C, Ramirez Flores RO, Li Z, Hayat S, Levinson RT, Liao X, et al. Spatial multi-omic map of human myocardial infarction. Nature. 2022;608(7924):766\u201377. https:\/\/doi.org\/10.1038\/s41586-022-05060-x.","journal-title":"Nature"},{"issue":"1","key":"485_CR414","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30549-4","volume":"13","author":"A Ma","year":"2022","unstructured":"Ma A, Xin G, Ma Q. The use of single-cell multi-omics in immuno-oncology. Nat Commun. 2022;13(1):2728. https:\/\/doi.org\/10.1038\/s41467-022-30549-4.","journal-title":"Nat Commun"},{"issue":"14","key":"485_CR415","doi-asserted-by":"publisher","DOI":"10.3390\/cells14141109","volume":"14","author":"KC Oxe","year":"2025","unstructured":"Oxe KC, Rohrberg KS, Lassen U, Larsen DH. A high-throughput immunoHistoFluorescence (IHF) method for sub-nuclear protein analysis in tissue. Cells. 2025;14(14):1109. https:\/\/doi.org\/10.3390\/cells14141109.","journal-title":"Cells"},{"issue":"20","key":"485_CR416","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15204996","volume":"15","author":"V Roman","year":"2023","unstructured":"Roman V, Mihaila M, Radu N, Marineata S, Diaconu CC, Bostan M. Cell culture model evolution and its impact on improving therapy efficiency in lung cancer. Cancers. 2023;15(20):4996. https:\/\/doi.org\/10.3390\/cancers15204996.","journal-title":"Cancers"},{"issue":"20","key":"485_CR417","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl3511","volume":"10","author":"H Song","year":"2024","unstructured":"Song H, Jiang H, Hu W, Hai Y, Cai Y, Li H, et al. Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids. Sci Adv. 2024;10(20):eadl3511. https:\/\/doi.org\/10.1126\/sciadv.adl3511.","journal-title":"Sci Adv"},{"key":"485_CR418","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2025.107742","volume":"171","author":"R Doerfler","year":"2025","unstructured":"Doerfler R, Chen J, Kim C, Smith JD, Harris M, Singh KB, et al. Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer. Oral Oncol. 2025;171:107742. https:\/\/doi.org\/10.1016\/j.oraloncology.2025.107742.","journal-title":"Oral Oncol"},{"key":"485_CR419","doi-asserted-by":"publisher","DOI":"10.3791\/54828","volume":"126","author":"SC McAllister","year":"2017","unstructured":"McAllister SC, Hanson RL, Grissom KN, Botto S, Moses AV. An in vitro model for studying cellular transformation by Kaposi sarcoma herpesvirus. J Vis Exp. 2017;126:54828. https:\/\/doi.org\/10.3791\/54828.","journal-title":"J Vis Exp"},{"issue":"10","key":"485_CR420","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1093\/jimmun\/vkaf231","volume":"214","author":"TI Michalak","year":"2025","unstructured":"Michalak TI. Immunological aspects of naturally occurring model of hepatitis B virus (HBV) infection, hepatitis B, and HBV-associated hepatocellular carcinoma in the American woodchuck Marmota monax. J Immunol. 2025;214(10):2504\u201314. https:\/\/doi.org\/10.1093\/jimmun\/vkaf231.","journal-title":"J Immunol"},{"issue":"7","key":"485_CR421","doi-asserted-by":"publisher","DOI":"10.1172\/JCI152069","volume":"132","author":"ME Verhaegen","year":"2022","unstructured":"Verhaegen ME, Harms PW, Van Goor JJ, Arche J, Patrick MT, Wilbert D, et al. Direct cellular reprogramming enables development of viral T antigen-driven Merkel cell carcinoma in mice. J Clin Invest. 2022;132(7):e152069. https:\/\/doi.org\/10.1172\/JCI152069.","journal-title":"J Clin Invest"},{"issue":"1","key":"485_CR422","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-20098-3","volume":"15","author":"DA Rauch","year":"2025","unstructured":"Rauch DA, Harding J, Joseph A, Ratner L. Viral oncogenes drive biphenotypic lymphoproliferative malignancy in transgenic mice. Sci Rep. 2025;15(1):36325. https:\/\/doi.org\/10.1038\/s41598-025-20098-3.","journal-title":"Sci Rep"},{"issue":"12","key":"485_CR423","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1152\/physiolgenomics.00011.2024","volume":"56","author":"R Tambi","year":"2024","unstructured":"Tambi R, Zehra B, Vijayakumar A, Satsangi D, Uddin M, Berdiev BK. Artificial intelligence and omics in malignant gliomas. Physiol Genomics. 2024;56(12):876\u201395. https:\/\/doi.org\/10.1152\/physiolgenomics.00011.2024.","journal-title":"Physiol Genomics"},{"issue":"7","key":"485_CR424","doi-asserted-by":"publisher","DOI":"10.3390\/genes15070903","volume":"15","author":"X Cheng","year":"2024","unstructured":"Cheng X. A comprehensive review of HER2 in cancer biology and therapeutics. Genes Basel. 2024;15(7):903. https:\/\/doi.org\/10.3390\/genes15070903.","journal-title":"Genes Basel"},{"issue":"1","key":"485_CR425","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1001\/jamaoto.2025.3225","volume":"152","author":"GS Dayan","year":"2026","unstructured":"Dayan GS, H\u00e9nique G, Bahig H, Nelson K, Brodeur C, Christopoulos A, et al. Artificial intelligence model for imaging-based extranodal extension detection and outcome prediction in Human Papillomavirus-positive oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2026;152(1):7\u201317. https:\/\/doi.org\/10.1001\/jamaoto.2025.3225.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"485_CR426","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71657-z","volume":"14","author":"R Chaiteerakij","year":"2024","unstructured":"Chaiteerakij R, Ariyaskul D, Kulkraisri K, Apiparakoon T, Sukcharoen S, Chaichuen O, et al. Artificial intelligence for ultrasonographic detection and diagnosis of hepatocellular carcinoma and cholangiocarcinoma. Sci Rep. 2024;14(1):20617. https:\/\/doi.org\/10.1038\/s41598-024-71657-z.","journal-title":"Sci Rep"},{"issue":"1","key":"485_CR427","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101219","volume":"7","author":"PLH Yu","year":"2024","unstructured":"Yu PLH, Chiu KW, Lu J, Lui GCS, Zhou J, Cheng HM, et al. Application of a deep learning algorithm for the diagnosis of HCC. JHEP Rep. 2024;7(1):101219. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101219.","journal-title":"JHEP Rep"},{"issue":"10","key":"485_CR428","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104697","volume":"26","author":"DL Chung","year":"2025","unstructured":"Chung DL, Leung GHD, Liu S, Lok SWY, Xin Y, Xia Y, et al. AI-driven drug target screening platform identified oncogene CACNA2D1 activated by enhancer infestation in Epstein-Barr Virus-associated nasopharyngeal carcinoma. Int J Mol Sci. 2025;26(10):4697. https:\/\/doi.org\/10.3390\/ijms26104697.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"485_CR429","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01194-24","volume":"98","author":"J Zhen","year":"2024","unstructured":"Zhen J, Chen J, Huang H, Liao S, Liu S, Yuan Y, et al. Structures of Epstein-Barr virus and Kaposi\u2019s sarcoma-associated herpesvirus virions reveal species-specific tegument and envelope features. J Virol. 2024;98(11):e0119424. https:\/\/doi.org\/10.1128\/jvi.01194-24.","journal-title":"J Virol"},{"issue":"1","key":"485_CR430","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-14974-4","volume":"25","author":"F Farzaneh","year":"2025","unstructured":"Farzaneh F, Soltani A, Dastyar F, Mohammadi M, Hosseini MS. AI-driven predictive modeling of cervical intraepithelial neoplasia severity: A comprehensive analysis with clinical adoption frameworks. BMC Cancer. 2025;25(1):1521. https:\/\/doi.org\/10.1186\/s12885-025-14974-4.","journal-title":"BMC Cancer"},{"issue":"2","key":"485_CR431","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jhep.2021.09.025","volume":"76","author":"HY Kim","year":"2022","unstructured":"Kim HY, Lampertico P, Nam JY, Lee HC, Kim SU, Sinn DH, et al. An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic Hepatitis B. J Hepatol. 2022;76(2):311\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2021.09.025.","journal-title":"J Hepatol"},{"key":"485_CR432","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.05.042","volume":"23","author":"T Minami","year":"2023","unstructured":"Minami T, Sato M, Toyoda H, Yasuda S, Yamada T, Nakatsuka T, et al. Machine learning for individualized prediction of hepatocellular carcinoma development after the eradication of Hepatitis C virus with antivirals. J Hepatol. 2023;23:00424-5. https:\/\/doi.org\/10.1016\/j.jhep.2023.05.042.","journal-title":"J Hepatol"},{"key":"485_CR433","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00878","volume":"8","author":"S Di Franco","year":"2017","unstructured":"Di Franco S, Turdo A, Todaro M, Stassi G. Role of Type I and II Interferons in colorectal cancer and melanoma. Front Immunol. 2017;8:878. https:\/\/doi.org\/10.3389\/fimmu.2017.00878.","journal-title":"Front Immunol"},{"key":"485_CR434","doi-asserted-by":"publisher","unstructured":"Hu Z, Liu W, Liu J, Zhou H, Sun C, ChaoTian, et al. The anti-tumor efficacy of a recombinant oncolytic herpes simplex virus mediated CRISPR\/Cas9 delivery targeting in HPV16-positive cervical cancer. Antiviral Res. 2024;232:106035. https:\/\/doi.org\/10.1016\/j.antiviral.2024.106035.","DOI":"10.1016\/j.antiviral.2024.106035"},{"issue":"4","key":"485_CR435","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2025.201050","volume":"33","author":"T Inagaki","year":"2025","unstructured":"Inagaki T, Espera JM, Wang KH, Komaki S, Nair S, Davis RR, et al. Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseases. Mol Ther Oncolytics. 2025;33(4):201050. https:\/\/doi.org\/10.1016\/j.omton.2025.201050.","journal-title":"Mol Ther Oncolytics"},{"key":"485_CR436","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1308890","volume":"14","author":"L Chen","year":"2023","unstructured":"Chen L, Zuo M, Zhou Q, Wang Y. Oncolytic virotherapy in cancer treatment: challenges and optimization prospects. Front Immunol. 2023;14:1308890. https:\/\/doi.org\/10.3389\/fimmu.2023.1308890.","journal-title":"Front Immunol"},{"issue":"4","key":"485_CR437","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/imm.13325","volume":"163","author":"M Riera Romo","year":"2021","unstructured":"Riera Romo M. Cell death as part of innate immunity: cause or consequence? Immunology. 2021;163(4):399\u2013415. https:\/\/doi.org\/10.1111\/imm.13325.","journal-title":"Immunology"},{"issue":"27","key":"485_CR438","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj7402","volume":"10","author":"W Robinson","year":"2024","unstructured":"Robinson W, Stone JK, Schischlik F, Gasmi B, Kelly MC, Seibert C, et al. Identification of intracellular bacteria from multiple single-cell RNA-seq platforms using CSI-Microbes. Sci Adv. 2024;10(27):eadj7402. https:\/\/doi.org\/10.1126\/sciadv.adj7402.","journal-title":"Sci Adv"},{"issue":"10","key":"485_CR439","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.ccell.2022.09.009","volume":"40","author":"B Ghaddar","year":"2022","unstructured":"Ghaddar B, Biswas A, Harris C, Omary MB, Carpizo DR, Blaser MJ, et al. Tumor microbiome links cellular programs and immunity in pancreatic cancer. Cancer Cell. 2022;40(10):1240-1253.e5. https:\/\/doi.org\/10.1016\/j.ccell.2022.09.009.","journal-title":"Cancer Cell"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00485-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00485-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00485-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:35:26Z","timestamp":1783492526000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00485-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":439,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["485"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00485-6","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}